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ABSTRACT 
Prenatal methamphetamine exposure is associated with functional and neurostructural 
alterations, but neuroimaging investigations of these effects in infants are almost non-existent. 
Studies in neonates permit a degree of separation of drug exposure effects from potential 
confounders in the postnatal environment. Magnetic resonance imaging (MRI) was used to 
investigate the neurostructural effects of prenatal methamphetamine exposure on neonates 
recruited from a Cape Town community.  
Mothers were recruited during pregnancy and interviewed regarding methamphetamine use. 
Women in the exposure group used methamphetamine at least twice per month during 
pregnancy, while control mothers did not use methamphetamine. MRI scans were acquired 
within the first postnatal month. Anatomical images were processed using FreeSurfer and 
subcortical and cerebellar structures manually segmented with Freeview. Volumes were 
regressed with methamphetamine exposure (days/month of pregnancy) and related 
confounding variables, including total brain volume, gestational age at scan, exposure to 
cigarette smoking and infant sex. Diffusion data were processed with FSL, and diffusion 
tensors and tensor parameters determined using AFNI. Probabilistic tractography defined white 
matter connections between target regions. For the first analysis, five major white matter 
networks (commissural, and bilateral projection and association networks) were defined 
between spherical targets. For the second analysis, regions traced in the anatomical study were 
used as targets. Averaged DTI parameters were then calculated for each connection, and 
multiple regression analysis determined associations between DTI parameters and 
methamphetamine exposure at network level and in the individual connections. 
Methamphetamine exposure was associated with reduced caudate nucleus volume bilaterally, 
and in the right caudate following adjustment for confounders. Exposure was associated with 
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reduced fractional anisotropy in all major white matter networks, and in individual connections 
within the limbic meso-cortico-striatal circuit. Exposure was associated with increased radial 
diffusivity in a subset of these. 
These results support findings in older children of methamphetamine-induced neurostructural 
damage, and demonstrate that such effects are already measurable in neonates. Corticostriatal 
circuit changes may underlie the impaired executive function observed in prenatally exposed 
children, and suggest a specific mechanism of damage in dopaminergic-related circuits that is 
consistent with the neurotoxic actions of methamphetamine.  
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PREFACE 
This thesis presents a multi-faceted MRI investigation into the effects of prenatal 
methamphetamine exposure on the central nervous system of neonates. Methamphetamine 
abuse is a significant issue in the Cape Flats region of the Western Cape, South Africa, and 
although some literature exists showing the effects of in utero exposure in older children, 
investigations during the neonatal period are almost non-existent.  
This thesis contains three original articles, comprising chapters three to five. Each chapter is 
presented as an independent article which will be submitted for publication shortly. Each thus 
follows the traditional journal article format of introduction, methods, results and discussion, 
permitting the presentation and evaluation of each study. This dissertation format, however, 
necessitates a degree of repetition, particularly as regards aspects of the background and 
preliminary methodology in each study. Presented below is a description of each chapter and 
the contributions of co-authors to each study. 
Chapter one is an in-depth introduction, providing a social context to the methamphetamine 
problem in the geographical region under study, followed by a presentation and analysis of the 
available literature on the neurostructural effects of methamphetamine use. 
Chapter two provides background theory on the embryological development of the nervous 
system, the anatomical structure and connectivity of the basal ganglia, the mechanisms of 
action of methamphetamine, which includes a description of dopaminergic neurotransmission 
under physiological conditions, and the introductory principles of MRI. Chapter two also 
includes a more thorough description and explanation of some aspects of the methodology 
which fell outside the scope of the journal article format of chapters three to five. 
Chapter three is an article describing a volumetric analysis of subcortical brain regions of 
neonates using structural MRI. I am the primary author of this article, with assistance from all 
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co-authors. My primary supervisor, Ernesta Meintjes, provided overall project supervision. 
Ernesta Meintjes and principal co-investigators Joseph Jacobson and Sandra Jacobson 
conceptualised the original study as a sub-set of an ongoing longitudinal cohort study 
investigating the effects of prenatal alcohol exposure in infants from the Cape Flats. As such, 
neonatal scanning of the infants investigated in this study was performed as part of the larger 
study and was supervised by Christopher Molteno following a protocol designed by Pia 
Wintermark. I assisted with the scanning of all infants, and performed the post-processing of 
each scan, following initial technical assistance from Andre van der Kouwe and Lilla Zöllei 
with data synthesis. My co-supervisor Christopher Warton provided expert anatomical 
guidance on manual segmentation. Nadine Lindinger independently retraced nine brains for 
inter-rater reliability purposes. Ernesta Meintjes, Joseph Jacobson and Sandra Jacobson gave 
guidance with statistical analysis. I drafted the manuscript, with co-authors providing editorial 
and technical input on later drafts.  
Chapters four and five describe diffusion tensor imaging (DTI) analyses of white matter regions 
of the scanned neonates. Chapter four details a whole-brain approach, in which global white 
matter was investigated in five major networks (commissural fibres, and projection and 
association fibres bilaterally). Chapter five details the use of the regions traced in chapter three 
as seeds for tractographic analysis of cortico-striatal and mesolimbic white matter connections. 
As described for chapter 3, these studies formed part of the larger cohort study, and as such, 
the conceptual and technical contributions by Ernesta Meintjes, Sandra Jacobson, Joseph 
Jacobson and Christopher Molteno are as described above. Ernesta Meintjes provided overall 
project supervision. Paul Taylor provided guidance and technical assistance with pre-
processing and data analysis, as well as statistical guidance for chapter 4 particularly. 
Christopher Warton assisted with anatomical analysis and interpretation. I drafted the 
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manuscripts for both chapters, with technical and editorial input on further drafts from Ernesta 
Meintjes, Christopher Warton and Paul Taylor. 
Chapter six is a summary and evaluation of the findings in the light of previous literature, and 
discusses patterns and potential mechanisms of methamphetamine effects and the possible 
functional significance thereof. 
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INTRODUCTION 
Methamphetamine is one of the most widely used illicit drugs, with recent estimates suggesting 
that global amphetamine use is second only to cannabis1. Amphetamine dependency was 
determined in 2010 to have a global point prevalence of 0.25%1, making it one of the two most 
common drug dependencies worldwide2.  
With the transition to democracy in the 1990s and the associated rapidly changing social and 
economic landscape, drug availability and abuse has become a significant societal pathology 
in South Africa3,4. The lifetime prevalence of substance use disorders in South Africa has been 
estimated at over 13%5, which includes a high incidence of alcohol abuse and the use of illicit 
drugs such as marijuana, cocaine, amphetamines and opiates4. Prior to 2002, methamphetamine 
was relatively rarely used and unavailable, with only 0.2-0.7% of patients in substance abuse 
treatment centres in the greater Cape Town area reporting methamphetamine as their primary 
drug of abuse6,7. However, the rate of methamphetamine use has increased sharply since then. 
In 2006, the proportion of patients reporting methamphetamine as their primary drug of abuse 
was 52%6, and another study suggested it to be as high as 59%7. The Western Cape province 
reports the highest incidence of methamphetamine use in South Africa8, where it is particularly 
high in the ‘Coloured’ communities of the Cape Flats3,4,8. The term ‘Coloured’ is a 
demographic descriptive which originated in the apartheid era and is used to refer to individuals 
of mixed ancestry (African, European and/ or Asian)8,9. Methamphetamine use on the Cape 
Flats has been strongly linked with the pervasive and unique gang culture of the area4, and is 
associated with increased interpersonal violence, mental health issues and sexual risk 
behaviours10–12. 
Methamphetamine is a psychostimulant, acting primarily to increase extracellular levels of the 
neurotransmitters dopamine, serotonin and norepinephrine in the central nervous system 
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(CNS)13. The mechanisms by which it modulates neurotransmitter levels are not fully 
understood, but are distinct from normal physiological transmitter release via secretory vesicle 
fusion14, and appear to involve reverse transport of monoamines through membrane and vesicle 
transporters15,16. Although methamphetamine alters the release of several neurotransmitters, 
research has focused chiefly on the activity of methamphetamine in dopaminergic systems, 
given the fundamental role that this transmitter plays in cognition, motivation and reward17.  
A considerable body of literature provides cogent evidence that methamphetamine induces 
damage in the CNS. Structural magnetic resonance imaging (MRI) studies show that 
methamphetamine use is associated with volume alterations of striatal18–20 and cortical21,22 
regions, as well as of the hippocampus and amygdala23–25. Diffusion tensor imaging (DTI) 
permits the visualisation and characterisation of white matter, and the determination of 
microstructural alterations in fibre bundles within the brain by means of analysis of water 
molecule diffusion in specific regions of interest26,27. DTI studies have revealed reduced 
microstructural integrity in frontal white matter and corpus callosum (CC)28–31 in individuals 
who used methamphetamine, while investigations using magnetic resonance spectroscopy 
(MRS) show methamphetamine-associated alterations in neurometabolites in frontal white 
matter and basal ganglia32–37. Methamphetamine users have been shown to exhibit functional 
deficits in a range of domains, including poorer executive function38,39, inhibition40, cognitive 
control29,41 and attention42,43, and increased impulsivity44,45, as well as increased incidence and 
severity of psychiatric symptoms46–48. Several studies additionally showed these functional 
deficits to correlate with specific structural changes, including reduced density of dopamine 
receptors45 and transporters47–49 in striatal and prefrontal regions, and functional MRI (fMRI) 
investigations of methamphetamine users have demonstrated reduced activation of prefrontal 
cortical regions in the performance of tests of executive function compared to controls41,50–52.  
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Peak methamphetamine prevalence has been shown to occur between 20-35 years of age1. It is 
thus to be expected that a proportion of women will use methamphetamine while pregnant. In 
the United States, the incidence of pregnant women seeking treatment for methamphetamine 
abuse rose from 8% in 1994 to 24% in 200653. Arria and colleagues determined that 5.2% of 
pregnant women in a 4-centre study in the United States had used methamphetamine during 
pregnancy54. Within the vulnerable social context of the Cape Flats, use of methamphetamine 
by pregnant women is not uncommon8, particularly in the light of the increased incidence of 
sexual risk behaviours6, including significantly reduced condom use55, by methamphetamine-
using women of child-bearing age. In one investigation of drug-using women on the Cape Flats, 
92% of pregnant Coloured women reported methamphetamine as their drug of choice56. A 
significant number of children in this community are thus exposed to methamphetamine during 
prenatal development, making investigations into the effects of such exposure a matter of 
priority.  
Methamphetamine use during pregnancy has been observed to be associated with increased 
risk of perinatal complications. It causes vasoconstriction and reduced blood flow to the 
placenta57, with consequent restriction of oxygen and nutrient supply to the fetus58. These 
infants experience reduced intrauterine growth59 and are more likely to be born early60–62 and 
small for gestational age63–66. In the neonatal period they exhibit increased signs of stress and 
lower arousal67–69.  
In the light of these general physiological effects, and given the aforementioned neurotoxicity 
of methamphetamine in adult users, and its documented ability to cross the placenta70,71 it is to 
be expected that exposure to methamphetamine during the prenatal period will result in similar 
damaging effects on the infants concerned. The CNS undergoes rapid growth and development 
during this period72, with dopaminergic neurons and receptors appearing within the first few 
months of gestation73. Exposure to the neurotoxic insult of methamphetamine in utero may 
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thus induce long-term modifications in neuronal circuits which have been shown to be affected 
in adult users.  
Investigation of the behavioural, psychological and cognitive characteristics of children with 
prenatal exposure to methamphetamine suggest that the effects are subtle but definite. 
Compared to unexposed controls, methamphetamine exposed infants display poorer quality of 
movement67 and delayed motor development74, and exhibit deficient fine motor performance 
in the first three postnatal years74,75. Poor psychomotor development and emotional adjustment 
was observed in methamphetamine exposed children at four years old76, and a follow-up 
investigation of the same cohort noted aggressive behaviour at eight years of age77, a finding 
which was similarly observed in a larger multi-site investigation of school-age children78. 
Methamphetamine exposure has also been associated with increased risk of affective problems 
such as anxiety and depression79,80. A number of investigations have demonstrated that children 
with prenatal exposure to methamphetamine have deficits in executive function80–82, including 
poorer inhibitory control83,84, and an increased incidence of the symptoms and clinical 
diagnosis of attention deficit/ hyperactivity disorder (ADHD) has been noted79,85.  
Given these functional outcomes, it is reasonable to assume that they might be underpinned by 
structural changes in the CNS, and there is a small but convincing body of literature which 
suggests that such changes do indeed occur following prenatal exposure to methamphetamine.  
MRI provides non-invasive means for the investigation of structural, metabolic and functional 
characteristics of the CNS, and is thus a valuable tool for measuring potential neurological 
changes associated with prenatal drug exposure26. An fMRI study showed that children with 
prenatal methamphetamine exposure performed more poorly than controls in a verbal memory 
task, and activated more diffuse brain regions, including medial temporal, parietal and frontal 
cortex and the basal ganglia, in order to achieve a comparable level of performance to that of 
21 
 
the unexposed controls86. Exposed children were similarly shown to exhibit deficits in a task 
of working memory, and displayed reduced recruitment of the thalamus and left frontal cortex 
and basal ganglia compared to unexposed control children87. Altered levels of neurometabolites 
in the striatum and frontal white matter following methamphetamine exposure have been 
observed in several MR spectroscopy studies88,89, suggesting that such exposure is associated 
with alterations in metabolism in these regions. 
The neuroimaging literature investigating the structural changes associated with prenatal 
methamphetamine exposure is extremely limited. A handful of DTI studies have demonstrated 
that such exposure is associated with white matter changes, but the results are not unanimous 
as to the exact nature of these changes. Reduced fractional anisotropy (FA) and increased 
diffusion have been observed in white matter connections traversing striatal, limbic and frontal 
regions of 6-7 year-olds with prenatal methamphetamine exposure82. Similar changes were 
noted in the corona radiata of methamphetamine- and tobacco- exposed infants in the first four 
postnatal months90. Other research, by contrast, found methamphetamine exposure to be 
associated with increased FA and reduced diffusivity in the genu and splenium of the CC, 
frontal and parietal white matter, and basal ganglia of 3-4 year-olds91, and with higher FA in 
the genu, corona radiata and internal and external capsules of 9-11 year old children92. 
Methamphetamine exposure in utero has been shown in a small number of anatomical MRI 
studies to be associated with volume changes of specific brain regions. In children with 
concomitant methamphetamine and alcohol exposure, volumes of the striatum, thalamus and 
left parieto-occipital and right anterior prefrontal cortices were reduced, while anterior and 
posterior cingulate, ventral and medial temporal lobes and bilateral perisylvian cortices were 
increased in volume compared to unexposed control children, with volume changes in the 
methamphetamine and alcohol exposed subjects more severe than those observed in the cohort 
with alcohol exposure alone93. Reduced volumes of putamen and pallidum, with a trend 
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towards reduction in the volumes of the caudate, thalamus, hippocampus and cerebellum, were 
observed in another study of methamphetamine exposed children of a similar age, and the 
pallidal, putamenal and hippocampal changes correlated with poorer performance on tasks of 
sustained attention, verbal memory and visual motor integration94. In a study of 3-5 year-old 
children with prenatal methamphetamine and tobacco exposure, caudate volumes were 
significantly reduced and orbitofrontal and perisylvian cortical volumes were increased, with 
the former inversely related to a measure of cognitive flexibility95. In contrast to these findings, 
however, one study found increased striatal volumes in methamphetamine-exposed 6-year-
olds96. 
A coherent body of research thus demonstrates that exposure to methamphetamine in utero has 
considerable and persisting effects on the brain, with effects repeatedly being observed in 
dopaminergic regions such as the basal ganglia and fronto-striatal circuitry, as well as in certain 
non-dopaminergic areas such as the hippocampus, thalamus, and cerebellum. The literature is, 
however, extremely sparse, and somewhat equivocal as to the exact direction of the observed 
changes. As Chang and colleagues observed, further detailed morphometric studies of the 
neurostructural changes associated with prenatal methamphetamine exposure are imperative in 
order to determine more clearly the alterations exhibited by these children88. Furthermore, 
investigations of prenatal drug exposure are inherently confounded by the effects of post-natal 
environment. The latter is likely to be suboptimal for a child born to a mother using 
methamphetamine59,60,65,81, and this itself will exert a strong effect on neural development that 
is distinct from the effects of prenatal drug exposure but may be difficult to quantify. These 
issues can largely be mitigated by investigations during the neonatal period. Studying neonates 
permits the separation of the effects of prenatal exposure from potential confounding effects in 
the postnatal environment. To our knowledge, however, only one study has investigated white 
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matter changes during the neonatal period90, and no research has examined potential volumetric 
changes in neonates following prenatal exposure to methamphetamine. 
The aim of the following studies was therefore to explore the neurostructural changes in 
neonates who were exposed to methamphetamine in utero, as compared to unexposed control 
infants, in a study sample drawn from the Cape Flats region of the Western Cape. The first 
study investigated potential volumetric changes in subcortical regions by means of manual 
segmentation of anatomical MR images. The second and third studies used DTI to investigate 
white matter alterations, in three major white matter classes, and specific fronto-striatal circuits, 
respectively.  
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CHAPTER 2 
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BACKGROUND 
2.1 EMBRYONIC DEVELOPMENT OF THE CENTRAL NERVOUS SYSTEM 
(See Refs97–104) 
2.1.1 Neurulation and proliferation 
At the end of the third week of gestation the embryo is a three-layered disc, consisting of the 
endoderm, the intermediate mesoderm and the ectoderm. Within the ectoderm are the 
neuroectodermal stem cells located along the rostro-caudal midline in a region referred to as 
the neural plate. Primary neurulation, or development of the neural tube, begins in weeks 3-4 
of gestation, and involves invagination and dorsal closure of the neural plate. The neural tube 
will ultimately form the CNS, with the spinal cord arising from the caudal aspects of the neural 
tube and the rostral region giving rise to the brain. Following the closure of the neural tube, 
cell proliferative areas are formed in the ventricular and subventricular zones surrounding the 
developing ventricular system. From these proliferative regions all the cells of the CNS are 
derived: the ventricular zone gives rise chiefly to neurons, while the subventricular zone 
produces both neurons and glial cells, with neural progenitor cells developing mainly between 
weeks 3 and 23 and glial cells from week 18 onwards. Cell proliferation in the rostral region 
of the neural tube results in the formation of three initial vesicles, the prosencephalon, or 
forebrain, the mesencephalon (midbrain), and the rhombencephalon (hindbrain). The forebrain 
and hindbrain vesicles later divide to form the telencephalon and diencephalon, and the 
metencephalon and myelencephalon, respectively (see Table 2.1). 
 
2.1.2 Neuronal migration 
From the third gestational month, neuronal migration occurs. Most neurons migrate actively in 
a radial pattern along a scaffold of glial cells, with earlier neurons finding their final location 
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Table 2.1. Major subdivisions of the embryonic central nervous system with their associated mature structures. 
Three-vesicle stage Five-vesicle stage Mature structures 
   Forebrain 
(prosencephalon) 
Telencephalon 
 
Cerebral cortex, basal ganglia, hippocampus, amygdala, 
olfactory bulb 
 Diencephalon Thalamus, hypothalamus, subthalamus, epithalamus, retina, 
optic nerves/ tracts 
   
Midbrain 
(mesencephalon) 
Mesencephalon  Midbrain 
   
Hindbrain 
(rhombencephalon) 
Metencephalon  Pons and cerebellum 
 Myelencephalon Medulla 
   (Adapted from Ref99) 
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in deeper layers of cortex and those of later generations settling in the more superficial layers. 
The earliest neurons to migrate form the preplate, which is the first recognisable cortical layer 
and which is present from about week 5 to week 8. The preplate then develops to form the 
cortical plate, which is bounded by the marginal zone superficially and the subplate on its inner 
side. The subplate plays an essential role in the organisation of the cerebral cortex and its 
connections. Differentiation of neurons occurs to some extent during migration, but the 
sprouting of axonal and dendritic processes takes place chiefly once the cells have reached their 
final location. The subplate provides a temporary waiting region for afferent fibres projecting 
from the thalamus, brainstem nuclei, basal forebrain and ipsilateral and contralateral 
hemispheres, and may also be involved in guiding cortifugal axonal projections. As the target 
neurons in the cortex mature, the afferent fibres relocate to the cortical plate and the subplate 
neurons undergo apoptosis. The subplate begins to regress in the third trimester of gestation 
and is gone by the sixth postnatal month. 
 
2.1.3 Synaptogenesis 
Cellular differentiation and organisation of the cortex occurs with increasing synaptogenesis. 
Once a neuron has reached its final position, it develops connections with other neurons. 
Developing axons are guided by their terminal growth cones, which respond to chemoattractor 
or chemorepellent cues, to form short projections, as in the case of interneurons, or significantly 
lengthier connections, such as those found in the monoaminergic systems, CC or corticofugal 
pathways. Formation of the latter leads to the development of long-distance bundles. Dendritic 
tree development occurs relatively slowly through the first two trimesters, and accelerates 
during the third trimester, with those of the subplate and deep cortical neurons maturing earlier 
than the more superficial cortical dendrites. As the dendritic and axonal connections develop, 
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synaptogenesis increases. The first synapses form in the spinal cord during the sixth gestational 
week, and in the cortex at around 7 weeks. Synaptic density increases homogeneously in the 
cortex until around 22 weeks, after which it rapidly accelerates in a region-specific manner 
until well after birth. Maximum synaptic density in the primary sensory areas occurs at 3 
postnatal months, while in the prefrontal cortex maximum density is not reached until 15 
months of age. 
 
2.1.4 Neural regression 
An important aspect of neurodevelopment is the orchestrated loss of neural elements. This 
consists of two main regressive phenomena intended to shape the structure and connectivity of 
the CNS, each of which are sensitive to exogenous factors to some extent. Programmed cell 
death, or apoptosis, is a process whereby cells undergo regulated cellular and molecular events 
which culminate in their death, and is essential in controlling the population of both neurons 
and glial cells. Significant numbers of cells in all brain regions are eliminated in this manner, 
with neural apoptosis occurring chiefly during the prenatal period while glial cell death occurs 
over a more protracted period that is predominantly postnatal. The second regressive process 
is synaptic pruning, which follows an initial vigorous overproduction of synaptic connections. 
This involves axonal retraction and elimination of a substantial proportion of connections and 
is essential for shaping local connectivity. 
 
2.1.5 Glial cells  
Glial cells surround and provide support for neurons in the CNS, and include two main forms: 
microglia and macroglia. Microglia infiltrate the brain during the fifth week of gestation and 
progressively colonise and cluster in different regions over the following weeks. They are 
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macrophages and fulfil essential immune functions within the brain, but are additionally 
involved in neurogenesis and synaptogenesis, the establishment of brain vasculature, and 
support of myelination during neurodevelopment. 
The two main forms of macroglial cells are astrocytes and oligodendrocytes. The latter are 
responsible for the myelination of axons in the CNS, while astrocytes have a range of functions 
which include extracellular regulation, neurotransmitter removal and modulation of synaptic 
structure and function. Macroglia arise from neural progenitor cells, with astrocytes developing 
after neurons but prior to oligodendrocytes in any given region of the CNS. Oligodendrocytes 
mature in four stages, namely, early and late oligodendrocyte progenitors, and immature and 
mature oligodendrocytes.  
 
2.1.6 Myelination and formation of white matter tracts 
Myelination, or the ensheathment of axons in myelin, is the final stage of white matter 
development and occurs subsequent to axonal development and pruning. During the pre-
myelinating phase, oligodendrocyte precursors proliferate and migrate, and form initiator 
processes which align themselves along axons. This is followed by the true myelination phase. 
Oligodendrocyte processes elongate and wrap around the axon, ultimately effecting several 
spiral turns that produce a more compact sheath. The myelin sheath matures in three stages. 
The premyelin sheath consists of immature oligodendrocytes and contains no myelin basic 
protein (MBP), an essential constituent of the mature myelin sheath. This is followed by the 
development of a transitional sheath, which contains MBP in some layers. The mature myelin 
sheath consists of mature oligodendrocytes and is characterised by MBP in all layers. 
Myelination is a predominantly postnatal process, although it occurs from the second half of 
pregnancy. The oligodendrocyte progenitors form during the embryonic phase (the first eight 
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weeks following conception), but only begin to proliferate and transform into oligodendrocytes 
in the 20th gestational week. Myelination of fibre tracts is significantly regionally 
asynchronous, and appears to follow the hierarchy of processing needs within the cortical 
connections, with regions responsible for low-level processing maturing earlier than those 
involved in higher functions. Despite the protracted development and maturation of the myelin 
sheath, however, all major white matter fibre systems are in place and identifiable at term. 
 
2.1.7 Neurotransmitters  
Neurotransmitters and neuromodulators play a significant part in the migration and 
differentiation of neural cells, and are essential for the modulation of synaptic connections. The 
presence and activity of transmitters ensure the survival of synapses, as neurons which do not 
release neurotransmitters undergo apoptosis following synaptogenesis. Environmental cues are 
important in the determination of neurotransmitter type for precursor neurons. 
The major neurotransmitters are present from early in the embryonic period. 
Catecholaminergic neurons are generated around the time of the formation of the telencephalic 
vesicle, and these neurotransmitters appear to be involved in gene regulation, and the regulation 
of the development, migration and maturation of cortical neurons. Dopaminergic cells are 
detectable in the spinal cord, medulla, pons, mesencephalon and hypothalamic region from the 
6th gestational week, while noradrenergic cells are identifiable in the pons, medulla and locus 
coeruleus at the same age. Two weeks later monoaminergic fibres make contact with the 
cortical anlage, and by 13 weeks they have reached the cortical plate. Dopaminergic and 
noradrenergic connections become detectable throughout the cerebral cortex between 20 and 
24 weeks, and by this stage their pattern of innervation resembles that of the adult brain, 
although dopaminergic innervation continues to develop for many years postnatally. 
31 
 
Serotonergic cells appear between the 5th and 12th gestational weeks, but serotonin is detectable 
long before that and is involved in the early development of the heart and craniofacial 
structures. Serotonergic neurons project to the forebrain during development and appear to play 
a role in the differentiation of neuronal progenitor cells and particularly in the detailed 
development of the sensory cortex and hippocampus. Serotonergic axons project throughout 
the cortex at birth, but their distribution declines significantly within the first postnatal month.  
Cholinergic neurons innervate the cortex around week 20, and appear to play an important role 
in cortical development and plasticity. Markers of acetylcholine are present earlier in the 
brainstem region, however. The amino acid transmitters, glutamate, aspartate, GABA and 
glycine, are suggested to be involved in neuronal wiring and cellular architecture.  
 
2.2 FUNCTIONS AND CONNECTIVITY OF THE BASAL GANGLIA CIRCUITS 
(See Refs17,99,105–107) 
2.2.1 Anatomical components of the basal ganglia 
The cerebral hemispheres are derived from the embryonic telencephalon, and make up the 
largest part of the brain. They include the cerebral cortex and underlying white matter, as well 
as several subcortical structures: the basal ganglia, the amygdala and the hippocampus. The 
basal ganglia work synergistically with the cortex to plan and execute motivated behaviours 
that require limbic, cognitive and motor functionalities. They are associated with many aspects 
of goal-directed behaviour leading to motor output, including emotion, motivation and 
cognition and the involvement of these elements in the control and production of movement. 
Within the basal ganglia, different regions are structurally and functionally involved in circuits 
subserving each of these modalities. Ventral regions are significant in reward and 
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reinforcement, while the central regions play a role in cognitive functions including memory 
and learning. The dorsolateral aspect of the basal ganglia functions in the control of movement. 
The basal ganglia consist of the striatum, the globus pallidus, the substantia nigra, and the 
subthalamic nucleus. The striatum can be divided into three regions: the caudate nucleus, the 
putamen, and the ventral striatum. The latter denotes that portion of the striatum which extends 
ventrally, and includes the nucleus accumbens, the medial and ventral parts of the caudate and 
putamen, and the olfactory tubercle. At its lateral and dorsal borders the ventral striatum merges 
with the dorsal striatum. The nuclei of the dorsal striatum, the caudate and the putamen, are 
divided by the internal capsule, a prominent area of white matter fibres connecting the thalamus 
and cerebral cortex. The globus pallidus and substantia nigra give rise to the major basal ganglia 
output projections. The globus pallidus is divided into the internal and external segments, while 
the substantia nigra consists of the pars reticulata and pars compacta. The pars compacta is 
continuous medially with the ventral tegmental area.  
 
2.2.2 Functional connections within the basal ganglia 
The striatum receives all major inputs to the basal ganglia, including excitatory glutamatergic 
afferents from the cortex and thalamus (see Fig. 2.1). The majority of neurons within the 
striatum are GABA-ergic medium spiny neurons (MSNs). These are both the targets of the 
input from the cortex, and the projection neurons responsible for all striatal output. The internal 
pallidum and the substantia nigra pars reticulata are the output nuclei of the basal ganglia. Their 
projections are GABA-ergic and exert a tonically inhibitory effect on target nuclei in the 
thalamus and brainstem. Two parallel pathways modulate the basal ganglia output: the direct 
and indirect pathways. In the direct pathway, the internal pallidum and substantia nigra pars 
reticulata receive inhibitory afferents directly from the striatum. In the indirect pathway, the 
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Figure 2.1. Diagrammatic representation of the major connections of the basal ganglia. Solid lines 
indicate excitatory connections; dashed lines indicate inhibitory connections. The direct pathway is 
indicated by blue lines, while the indirect pathway is depicted by red lines. DA: dopamine; Glu: 
glutamate; Ach: acetylcholine is the neurotransmitter produced by striatal interneurons. (Adapted from 
Ref112). 
 
striatum sends projections to the globus pallidus pars externa, which in turn projects to the 
subthalamic nucleus. The subthalamic nucleus then sends excitatory glutamatergic projections 
to the output nuclei. The thalamus completes the circuit by sending excitatory projections to 
the cortex. Activation of the direct pathway results in disinhibition of the thalamus and 
consequent activation of the thalamocortical neurons, while activation of the indirect pathway 
inhibits the thalamus and reduces thalamocortical neuronal firing. 
 
34 
 
2.2.3 Connections of the midbrain dopamine system 
The substantia nigra pars compacta and ventral tegmental area consist largely of dopaminergic 
cell bodies. The former give rise to fibres which synapse with MSNs of the dorsal striatum, in 
what is called the nigrostriatal pathway. Striatal MSNs can be divided into those which express 
D1 dopamine receptors, and those which express D2 receptors; these form part of the direct and 
indirect pathways respectively. Broadly speaking, D1 receptors have an excitatory effect on 
their associated MSNs, while D2 receptors are inhibitory. Neurons of the nigrostriatal 
projection thus facilitate activation of the direct pathway, or inhibit the indirect pathway. It has 
been suggested that the direct and indirect pathways may act synergistically under the influence 
of dopamine. In this model, the direct pathway rapidly primes a range of potential actions in 
several parallel pathways; the indirect pathway then inhibits those with weak reward 
association, to select the most appropriate or desirable response based on current physiological 
needs107. 
 Dopaminergic cells of the ventral tegmental area give rise to fibres which project primarily to 
the ventral striatum, and in particular the nucleus accumbens – the mesolimbic pathway. 
Dopaminergic fibres in the mesocortical pathway project from the ventral tegmental area and 
substantia nigra pars compacta to a number of cortical regions, with synapses in layer 1 of 
cortex acting as general cellular modulators while synapses in layers V and VI directly 
modulate corticostriatal and corticothalamic connections. The midbrain receives modulatory 
inputs from the cortex, striatum and globus pallidus. 
A fourth dopaminergic pathway, the tuberoinfundibular pathway, projects from the arcuate 
nucleus of the hypothalamus to the median eminence and is involved in the inhibition of 
prolactin release from the pituitary. 
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2.2.4 Parallel corticostriatal circuits 
The frontal cortex drives the basal ganglia, with several topographically and functionally 
distinct pathways responsible for controlling the components of goal directed behaviour. It can 
be divided into several anatomical and functional regions: the medial and orbitofrontal cortex 
(OFC), responsible for motivation and reward; the dorsolateral prefrontal cortex, responsible 
for executive functions; and the premotor and motor regions, responsible for planning and 
execution of motor function. The corticostriatal pathways preserve a distinct topographical 
organisation throughout each circuit. Projections from motor cortex terminate chiefly in the 
dorsolateral putamen; those from caudal premotor regions project to an adjacent putamenal 
area and slightly into the caudate nucleus, while the rostral premotor cortex sends fibres to both 
the putamen and caudate. Projections from somatosensory parietal cortex also synapse in these 
regions of the dorsal striatum, enabling sensorimotor integration and planning. The dorsolateral 
prefrontal cortex projects chiefly to the rostral striatum. The lateral OFC sends afferents to the 
central and lateral ventral striatum, while the medial OFC projects to the medial wall of the 
caudate and into the nucleus accumbens. The ventral striatum also receives afferents from the 
hippocampus and amygdala. 
 
2.3 METHAMPHETAMINE: PHARMACOLOGY AND MECHANISMS OF ACTION  
2.3.1 Dopamine neurotransmission 
 (See Refs99,105,108–112) 
Dopamine is a relatively slow-acting catecholaminergic neurotransmitter which functions 
generally to modulate glutamatergic and GABA-ergic neuronal activity. Under normal 
conditions, it is synthesised in the neuronal cell body by the sequential hydroxylation and 
decarboxylation of tyrosine by the enzymes tyrosine hydroxylase and dopa decarboxylase (see 
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Figure 2.2. Synthesis of dopamine from the amino acid tyrosine. (Adapted from Ref99). 
 
 
Figure 2.3. Dopamine neurotransmission. A. Secretion and release of dopamine. 1) Dopamine is 
synthesised in the neuronal cytoplasm and 2) transported into the synaptic vesicles by vesicular 
monoamine transporters (VMAT-2). 3) The vesicles are trafficked to the axon terminals where they are 
docked and primed on the presynaptic membrane. 4) The vesicles fuse with the axon membrane and 
release dopamine by exocytosis. The dopamine in the synaptic cleft can then bind with dopamine 
receptors on the post-synaptic membrane to induce enzymatic cascades in the post-synaptic neuron. 5) 
The vesicle is retrieved from the membrane and recycled. B. Removal of dopamine. 1) Reuptake 
through dopamine transporter (DAT) molecules; 2) Metabolic breakdown by a) monoamine oxidase 
(MAO) or b) catechol-O-methyl transferase (COMT); c) sequestration into vesicles via VMAT-2. 
(Adapted from Ref112) 
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Fig. 2.2 and Fig. 2.3A). It is transported from the cytoplasm into synaptic vesicles by means of 
the membrane transporter vesicular monoamine transporter-2 (VMAT2), where it accumulates 
in readiness for synaptic release. The acidic internal environment of the vesicles permits the 
maintenance of a pH gradient across the vesicle membrane, which provides the energy for 
dopamine transport. Vesicle acidity additionally results in the protonation and consequent 
sequestration of the basic neurotransmitter molecules. Vesicles are trafficked to presynaptic 
release sites in axon terminals and then to a docking site on the presynaptic membrane, where 
they are primed for fusion. The arrival of an action potential at the axon terminal activates a 
large influx of Ca2+ ions into the terminal. This results in the fusion of the vesicles with the 
axon membrane, and the release of the neurotransmitter via exocytosis into the synaptic cleft. 
The vesicles are then retrieved from the axon terminal membrane and recycled to form new 
vesicles.  
Dopamine released into the synaptic cleft exerts its effects by binding to receptor sites on the 
postsynaptic membrane. Dopamine receptors are G-protein coupled, or metabotropic, 
receptors, which trigger enzymatic cascades in the post-synaptic neuron when bound to 
dopamine. There are five dopamine receptors, which are divided into two main groups, D1- and 
D2-type receptors, based on their differing pharmacological, biochemical and structural 
properties. D1-type (D1 and D5) are excitatory and expressed exclusively on the post-synaptic 
membrane of dopamine-receptive neurons, such as MSNs in the striatum. D2-type (D2, D3 and 
D4), by contrast, are inhibitory, and are expressed on both the post-synaptic dopamine target 
cell and on the presynaptic neuron. Receptors located on the presynaptic neuron are designated 
autoreceptors, and play an important role in regulating neuronal firing and neurotransmitter 
synthesis and release by the presynaptic neuron in response to extracellular dopamine levels. 
If neurotransmitters were allowed to remain in the synaptic cleft, the receptors would be 
desensitised and the synapse would become refractory. Removal of the transmitter is thus 
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essential to ensure continued functioning of the synapse. There are several mechanisms by 
which dopamine is removed from the synaptic cleft (see Fig. 2.3B). Diffusion into the 
extracellular space passively removes a fraction of all transmitters. The majority of dopamine 
is, however, removed by means of reuptake through dopamine transporter (DAT) molecules in 
the presynaptic membrane. DAT is a 12-membrane-spanning molecule that undergoes several 
conformational changes during the reuptake of dopamine. Its initial outward-facing state 
permits the recognition of dopamine molecules, as well as Na+ and Cl- ions which are 
cotransported down their concentration gradients. These are taken up by DAT and translocated 
across the membrane. The transporter assumes an inward-facing conformation and releases the 
dopamine and ions into the neuronal cytoplasm, and then returns to its outward-facing state. 
DAT is thus responsible for terminating the transmission activity by the dopamine molecule, 
as well as for recycling dopamine for reuse or degradation. A subset of the dopamine molecules 
are metabolised in the neuronal cytoplasm by the mitochondrial membrane-associated enzyme 
monoamine oxidase (MAO). Dopamine is also catabolised by the extraneuronal enzyme 
catechol-O-methyl transferase (COMT). Dopamine which is not metabolised is recycled by re-
sequestration in synaptic vesicles via VMAT-2 for reuse in neurotransmission. 
 
2.3.2 Chemistry and pharmacology of methamphetamine 
(See Refs13,14,109,113–117) 
N-methyl-1-phenylpropan-2-amine, or methamphetamine, is the N-methyl derivative of its 
parent compound, amphetamine (see Fig.2.4A). It is a psychostimulant synthesised by the 
reduction of ephedrine or pseudoephedrine, and is stereoisomeric, with the d-isomer being the 
more biologically active and illicitly available enantiomer. It is available as a white powder or 
in a purer crystalline form, and is consumed orally, intranasally, intravenously or by vapour 
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Figure 2.4. A. Chemical structure of methamphetamine. B. Actions of methamphetamine to increase 
dopamine availability: 1) blockade of and promotion of reverse transport through DAT; 2) promotion 
of DAT internalisation; 3) redistribution of dopamine from vesicular to cytosolic stores; 4) inhibition 
of MAO; 5) enhanced dopamine synthesis. (Adapted from Ref13). 
 
inhalation (smoking). In South Africa, the primary route of consumption is by smoking of the 
crystalline form, known locally as ‘tik’58.  
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Methamphetamine has potent effects on both the central and peripheral nervous systems. Its 
sympathomimetic activity induces elevations in heart rate and blood pressure via 
vasoconstriction and bronchodilation, while vasodilation in skeletal muscles and 
hyperglycaemia enhance muscle activity. Levels of the stress-related hormones cortisol and 
ACTH are increased following methamphetamine consumption. Centrally, the acute effects of 
a low to moderate dose of methamphetamine include cognitive alterations such as increased 
arousal and improved attention and concentration. Affective changes are also observed, such 
as elevated mood and confidence, heightened libido and reduced appetite. Higher doses may 
result in anxiety, agitation and restlessness, as well as peripheral symptoms of excessive 
sympathetic activity. 
Methamphetamine acts primarily to increase extracellular levels of the monoamine 
neurotransmitters. Addiction to methamphetamine is believed to be underpinned by 
impairments in the corticostriatal circuits mediating executive function and impulse control. 
Methamphetamine-induced alterations in dopamine neurotransmission within the striatum 
result in dysregulated basal ganglia output, and are thus a dominant factor in the development 
and maintenance of drug dependence. Methamphetamine enhances dopamine release in several 
ways (see Fig.2.4B). Predominant, however, is its role in modulating the activity of two 
membrane transporters: DAT on the presynaptic membrane, and VMAT-2 on the vesicles.  
Methamphetamine functions primarily at DAT to promote reverse transport of dopamine from 
the cytosol into the synapse. The exact mechanisms whereby this is accomplished are not fully 
understood, but two primary mechanisms have been proposed. The facilitated exchange 
diffusion model involves the translocation of methamphetamine by DAT into the neuronal 
cytosol. The accompanying conformational change increases the availability of the DAT 
binding site to internal dopamine, which is then transported into the synapse. A second 
mechanism is the channel-like mode model, in which methamphetamine induces a 
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conformational change in DAT that permits an influx of ions, chiefly Na2+. The increase in 
cytosolic sodium ion concentration promotes the reverse transport of dopamine. It has also 
been suggested that methamphetamine promotes the internalisation of DAT, removing it from 
the plasma membrane and thereby reducing its availability to reduce synaptic dopamine, 
although this has not been conclusively demonstrated in vivo. 
The second primary mechanism by which methamphetamine increases dopamine levels is by 
redistribution of the neurotransmitter to the cytosol from vesicular stores. As with DAT, there 
is evidence for several means by which this is accomplished, which are not mutually exclusive. 
One putative mechanism, VMAT-2 competition, involves direct binding of methamphetamine 
to the vesicular transporter. This prevents the sequestration of dopamine via VMAT-2, so that 
it remains in the cytosol. Another proposed mechanism relies on methamphetamine’s chemical 
properties as a lipophilic weak base: in the acidic environment of the synaptic vesicle, it is 
protonated, becomes less membrane permeable, and accumulates. This results in a pH increase 
within the vesicle. Under normal conditions, the pH gradient provides the energy required for 
dopamine transport into the vesicle; the methamphetamine-induced gradient collapse thus 
reduces vesicular uptake of dopamine. Additionally, competition for protons occurs between 
dopamine and methamphetamine. An increased concentration of unprotonated dopamine 
molecules within the vesicle permits their passive diffusion into the cytosol. As with DAT, 
there is some evidence that methamphetamine causes a redistribution of VMAT-2 away from 
the vesicle membrane, which would further reduce dopamine transport. Increased levels of 
non-sequestered dopamine are thus available within the axon terminal for reverse transport into 
the synapse.  
There are several additional putative mechanisms by which methamphetamine may influence 
neurotransmitter availability. One such is the inhibition of MAO, which would reduce 
dopamine catabolism. Methamphetamine has also been shown to enhance dopamine synthesis, 
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which may be accomplished by promoting the activity of tyrosine hydroxylase. Non-
dopaminergic dependent mechanisms also appear to play a role: methamphetamine targets 
other monoaminergic transporters, such as those on noradrenergic neurons in the prefrontal 
cortex, which indirectly increase dopamine levels in the basal ganglia through their modulating 
influence on glutamatergic neurons in the corticostriatal pathways. 
 
2.4 MAGNETIC RESONANCE IMAGING 
2.4.1 Basic principles and terminology 
(See Refs99,118,119) 
MRI makes use of the magnetic properties of tissue to extract information about the structure 
and function of the anatomical region under consideration. This is accomplished by measuring 
signals from the hydrogen nuclei of water molecules in the tissue. The hydrogen nucleus is    
 
 
Figure 2.5. A. A proton rotating about its own axis generates a magnetic field. B. In an external 
magnetic field B0, a proton rotates about its own axis and also precesses about the axis of B0. (Adapted 
from Ref118). 
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composed of a single, positively charged proton, which spins about its axis and generates a 
magnetic field, or magnetic dipole moment (see Fig.2.5A). Under physiological conditions, the 
magnetic fields of the protons within the tissue are randomly directed so that the tissue as a 
whole has no net magnetisation.  
If the protons are placed in an external magnetic field B0, they experience a torque causing 
them not only to spin about their own axes, but also to rotate, or precess, around the axis of the 
external magnetic field (the z-axis of a three-dimensional system), resulting in a net 
magnetisation parallel to B0 (see Fig. 2.5B). The protons precess about B0 at a characteristic 
frequency γB0, where γ is the gyromagnetic ratio, known as the Larmor precession frequency. 
If a radiofrequency (RF) pulse is now transmitted along an axis perpendicular to the direction 
of B0, the x-axis for example, a second magnetic field (B1) is generated in this direction (see 
Fig. 2.6A). If the RF pulse has a frequency that exactly matches that with which the protons  
 
 
Figure 2.6. A. If a radiofrequency (RF) pulse is transmitted along an axis perpendicular to B0, a second 
magnetic field, B1, is generated in this direction. B. The net magnetisation rotates away from B0 into 
the transverse plane. C. The angle that M0 makes with the z axis following the RF pulse is called the 
flip angle (θ). (Adapted from Ref118). 
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are precessing, they will begin to precess additionally about the axis of B1, causing the net 
magnetisation to rotate away from an alignment parallel to B0 into the transverse plane (see 
Fig. 2.6B). This change of direction of the net magnetisation vector is called ‘flipping’, and the 
angle that M0 makes with the z-axis following the RF pulse is called the flip angle (see Fig. 
2.6C). The flip angle is determined by the duration and amplitude of the RF pulse.  M0 consists 
of two vector components: Mz, which is the component parallel to the B0 field, and Mxy, the 
component in the x–y plane. If, following the RF pulse, the magnitude of Mxy equals the 
magnitude of M0, the flip angle is 90° and the magnetisation has been completely flipped into 
the transverse plane.  
Once the RF pulse is switched off, the proton spins dephase and realign with the B0 axis, in a 
process called relaxation. During this process, the Mxy vector decreases rapidly owing to spin-
spin dephasing, while the Mz component recovers to its equilibrium state owing to spin-lattice 
relaxation, where the energy absorbed during excitation is returned to the lattice. Both of these 
processes are exponential. The time constant of the Mz recovery rate is called the longitudinal 
relaxation time, or T1. The transverse relaxation time, or T2, characterises the rate of decay of 
Mxy (see Fig. 2.7). These time constants are inherent properties of tissues and are thus fixed for 
a particular tissue at a given field strength. 
A coil is a device that can generate a magnetic field (gradient coils), or transmit or receive an 
RF pulse (RF coil). The RF coil detects a changing magnetic field as an induced electric current. 
As the flipped protons precess, their net magnetisation induces an oscillating current in the RF 
coil. The signal decays once the RF pulse is switched off as the protons dephase and relax. The 
received signal from one RF pulse is called a free induction decay (FID). 
A single FID is a composite of all the protons in the patient, and gives no information about 
the signal location. Gradients are thus used to specify the coordinates of the signal. Gradient 
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Figure 2.7. T1 represents the growth of magnetisation along the z axis, while T2 represents the decay 
of magnetisation in the x-y plane. The rate of decay of transverse magnetisation (T2) is several times 
greater than the rate of recovery of longitudinal magnetisation (T1). (Adapted from Ref118). 
 
coils produce an organised change in the homogeneity of the external magnetic field, thereby 
spatially encoding the signal. They consist of three orthogonal coils, each representing one of 
the gradients: the slice-select gradient (Gz), the phase-encoding gradient (Gy) and the 
frequency-encoding gradient (Gx), which are applied at different times during image 
acquisition.  
The time between the application of one RF pulse and the next is called the repetition time, or 
TR. If TR is less than the time taken for Mz to recover completely along the T1 curve, all 
successive FIDs will be reduced in magnitude compared to the first FID, as there will be less 
longitudinal magnetisation to flip, and smaller Mxys will be produced. After a pulse is applied, 
a period of time elapses before the measurement is taken; this period is called the time to echo, 
or TE. If the measurement was taken immediately after the pulse was applied, there would be 
no decay in the signal, and the maximum FID would be measureable. However, during TE 
some signal decay occurs according to the T2 curve. Thus the received signal will be a 
combination of the influence of T1 and T2. By manipulating TR and TE, the effects of T1 and 
T2 can be differentially enhanced or reduced in order to give better contrast between different 
tissues in an image (see Fig. 2.8). Increasing TR reduces the effect of T1, while increasing TE 
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Figure 2.8. Increasing TR reduces the effect of T1, while increasing TE increases the effect of T2. Short 
TR and TE will produce a T1-weighted image; long TR and TE will produce a T2-weighted image. 
(Adapted from Ref118). 
 
enhances the T2 effect. Thus by increasing TR and TE, a T2-weighted image can be obtained, 
in which the effect of T1 is mostly eliminated. By contrast, shorter TR and TE will produce a 
T1-weighted image. Different tissue types within the brain also have different proton densities 
(PDs), producing different relative intensities of signal, and different ‘brightness’ (see Table 
2.2).  
 
2.4.2 Diffusion tensor imaging 
(See Refs101,118,120–128) 
DTI uses magnetic imaging techniques to measure the diffusion of water. In a completely 
unrestricted environment, water molecules exhibit random translational movements, known as 
Brownian motion, as a consequence of their thermal energy. Various factors influence this 
diffusional motion. In the complex structural environment of tissue such as the brain, the 
movement of water molecules is significantly restricted. DTI is based on the fundamental 
principle that water diffusion in the nervous system is anisotropic; that is, it is not equal in all 
directions. In an environment where the restrictions are not directionally coherent, diffusion 
will be more isotropic than in one with highly organised and directionally cohesive barriers, 
and thus different tissue subtypes can be identified and characterised on the basis of the nature 
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Table 2.2. Relaxation times and appearance of central nervous system tissues in different MR 
images. 
   T1-weighted T2-weighted 
 T1 T2 Adult Infant Adult Infant 
White matter Intermediate Intermediate Bright Intermediate Dark Intermediate 
Gray matter Intermediate Intermediate Intermediate Bright Intermediate Dark 
CSF Long Long Dark Dark Bright Bright 
(Adapted from Refs118,177) 
 
of water diffusion within them. Within the CNS, white matter fibre bundles provide a 
significant level of organisation and directional coherence, with water molecule movement 
occurring preferentially along the length of axons and restricted by barriers such as neuronal 
membranes and the myelin sheath in a direction perpendicular to the axon. 
In diffusion weighted imaging, pulsed gradients provide a linearly varied magnetic field. The 
received signal is reduced by water movement in the direction of the gradient. Most simply, a 
single gradient pulse is followed by a second of equal magnitude but opposite direction, to 
rephase the proton spins. However, displacement of the water molecules before the refocusing 
phase results in incomplete spin recovery, and thus an attenuated signal. The b-value, which 
encapsulates the strength and timing of the gradient pulses used in the sequence, determines 
the sensitivity of the sequence to diffusion. In a completely isotropic environment, the rate of 
diffusion of water molecules can be adequately described by a single scalar parameter, namely, 
the diffusion coefficient D. DTI is an advanced form of diffusion MRI which investigates and 
characterises anisotropy. In an anisotropic environment, a single scalar is not sufficient to 
characterise diffusion. A minimum of 6 gradient pulses with non-zero b values (typically of 
the order of 700 – 1000 s/mm2) are applied in different directions in addition to a reference 
non-diffusion weighted acquisition (b = 0 s/mm2)). The diffusion in any given direction can 
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Figure 2.9. The diffusivity in three dimensions is modelled as an ellipsoid whose orientation is 
characterised by the eigenvectors e1, e2 and e3, and whose shape is defined by the eigenvalues λ1, λ2 and 
λ3. Completely isotropic diffusion within a voxel is modelled by a perfect sphere (A), while anisotropy 
is shown by the eccentricity of the ellipsoid (B). (Adapted from Ref193). 
 
then be determined by measuring the signal attenuation following diffusion weighting 
compared to the signal emitted with no diffusion weighting. Dx, Dy and Dz, represent diffusion 
along the principal axes. Three additional off-diagonal elements, Dxy, Dxz and Dyz, make up the 
tensor matrix, D.  
From the different components, the average diffusion or degree of anisotropy can be 
determined for each voxel. Additionally, the directionality and value of diffusion in each voxel 
can be calculated. The principal direction is titled the principal eigenvector (e1), with the 
diffusion coefficient in that direction known as the principal eigenvalue (λ1). This corresponds 
to the direction of greatest diffusivity. The two orthogonal eigenvectors, e2 and e3, with 
associated diffusivities λ2 and λ3, represent the lesser diffusion directions. These values and 
directionalities can be visualised by means of diffusion ellipsoids, which provide a 3-
dimensional representation of diffusion in each voxel of an image (see Fig. 2.9). The long axis 
of the ellipsoid represents the principal eigenvalue, while the radii indicate the second and third 
eigenvalues. The eccentricity of the ellipsoid is a visual indication of the degree of anisotropy 
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in the voxel, such that a perfectly spherical ellipsoid would be representative of complete 
isotropy. 
The diffusion tensor (DT) provides three main types of data which can be analysed in several 
ways to characterise the tissue under examination: diffusion, anisotropy, and orientation. Mean 
diffusivity (MD) characterises the overall displacement of molecules and presence of obstacles 
within each voxel without taking into account the directional variation. The degree of 
anisotropy is most commonly represented by FA; this is the normalised standard deviation of 
the three eigenvalues, and provides a measure of how they vary. This is complemented by 
examining the diffusivity along the principal axis (axial diffusivity, AD) and the diffusion in 
orthogonal directions, or contributions of λ2 and λ3 (radial diffusivity, RD). A third type of 
information that can be extracted from DTI images is related to the 3-dimensional orientation 
of the tissue structure. Based on the assumption that the principal eigenvalue represents 
movement of water along the white matter fibre length, the principal eigenvector is taken to 
indicate the 3-dimensional orientation of the fibres within the voxel.  
2.4.2i Strategies of analysis 
Once information has been extracted regarding each voxel, it can be analysed in several ways, 
as the precise anatomical locations of the diffusion variations are chiefly of interest. There are 
two main ways in which diffusion data can be analysed: voxel-based or regional analysis, and 
tractography. 
Whole brain voxelwise analysis examines specific diffusion measures in every voxel in the 
brain. This is particularly useful when there are no a priori hypotheses as to locations of 
significant interest. Spatial normalisation is used to align individual brains to a template so that 
the same structures are compared across the sample. Following this, voxels which meet a 
threshold value are individually processed and the results are statistically analysed for group 
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differences or correlation with some measure of interest. Limitations of this approach are that 
the normalisation process frequently results in distortion of brain images, particularly in clinical 
populations, and that the need arises to correct for multiple comparisons. A variation of this 
approach is Tract-based Spatial Statistics (TBSS), which creates a group mean FA skeleton by 
aligning the images of all subjects in a study into a common space. The FA skeleton is a 
representation of the centre of the fibre bundles common to all subjects. The FA data from each 
subject is then projected onto the skeleton and the FA value from the centre of the nearest 
relevant tract is used. Voxels selected in this way are then statistically analysed in the same 
way as for a whole brain voxelwise analysis. A drawback to this approach is that it excludes 
the peripheral voxels of white matter and may thus miss variations in those regions. 
Region of interest (ROI) analysis relies on selection of specific structures or regions where 
changes in diffusion measures are hypothesised to occur. These regions are defined, by manual 
delineation or automated segmentation, and only the voxels located within the regions are 
statistically analysed. An advantage of this method is that the reduced number of voxels 
increases the statistical power of the analysis, in contrast with whole brain approaches which 
must statistically correct for multiple comparisons. Manual segmentation provides the 
additional advantage that individual subject structural variation is taken into account and no 
distortion is necessary. However, it is time-consuming and labour-intensive. Automated 
segmentation is less laborious, but morphological distortion following normalisation is again a 
risk associated with this technique. 
Tractographic analysis involves the reconstruction of fibre tracts by the sequential connection 
of neighbouring voxels. The orientation of the fibres within a voxel are assumed from its 
principal eigenvector. This can then be extrapolated to connect to neighbouring voxels, and 
from this the fibre bundles can be reconstructed. Equivalent connections can thus be compared 
across subjects, and connections between anatomical ROIs can be investigated. Diffusion 
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measures can be averaged across tracts or segments of tracts for additional characterisation. 
Seeds, or defined ROIs, are used in tractography to define a location from where a tract will 
originate. Target regions are anatomical locations through which the fibres of a tract must pass. 
These ROIs may be defined manually or automatically, as described above. 
There are two chief methods of determining the trajectory of white matter bundles: 
deterministic and probabilistic tractography. Deterministic tractography assumes a single 
primary fibre direction in each voxel and connects neighbouring voxels based on their principal 
diffusion directions, or eigenvectors. Successive voxels are connected in this way until the tract 
terminates by reaching voxels unlikely to be located in the tract. Deterministic tractography 
has distinct limitations in voxels where fibre bundles cross. In such voxels the principal 
diffusion direction may no longer represent the fibre of interest and the continuing trajectory 
of the constructed tract may be incorrect. Probabilistic tractography does not assume a single 
orientation in a voxel based on the principal diffusion direction. Rather, variation and 
uncertainty in diffusion measures are taken into account and whole brain tractography is run 
with multiple iterations, with voxel parameters altered slightly each time. The result is a 
probability distribution for each voxel showing the most likely locations of white matter 
connections between the defined ROIs. This method permits the identification of a number of 
white matter pathways in areas where fibres cross. 
 
2.4.3 MR Imaging of neonates 
MRI is a non-invasive technique which does not involve ionising radiation, and is thus safe for 
use in infants. It is valuable for imaging subtle structural alterations which may not be visible 
using other modalities. MR imaging in neonates, however, does not simply involve the 
application of adult acquisition and post-processing protocols to the infant context. A variety 
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of factors must be taken into account when imaging neonates in order to achieve optimal 
visualisation. 
The neonatal brain is not merely an adult brain in miniature. The water content of the infant 
brain is much higher than that of an adult brain. Although the basic structures of the adult brain 
are present in the infant, they are significantly immature. Fibre bundles are chiefly in place, but 
myelination is incomplete. T1 and T2 relaxation rates are much longer in neonates, and the 
tissue contrasts in T1-weighted and T2-weighted images are very different in infants from those 
of adult brains. In the neonate, the contrasts are reversed, with T1-weighted images showing 
lower white matter than grey matter intensity, while T2-weighted images show higher grey 
than white matter signal intensity. However, given the incomplete myelination of the neonatal 
brain, the contrast is not merely an anatomical reversal of adult images; regional asynchrony 
of maturation results in some fibre bundles having the appearance of grey matter, while others 
are visualisable as white. As a result, the definition of boundaries between grey and white 
matter is not always very clear. Additionally, automated segmentation of anatomical MR 
images depend on previously defined atlases, of which the majority are based on adult brains, 
to which neonatal brains do not normalise well or accurately.  
DTI is a useful tool for imaging white matter in neonates, and well suited to gathering 
information which may not be measurable via other MR modalities. Although the neonatal 
brain is incompletely myelinated, the fibre bundles are well organised, leading to intrinsic 
anisotropy based on high parallel and low perpendicular diffusivity. The lack of myelin in many 
areas, however, makes it necessary to use a lower FA threshold for tractography than would be 
the case in adult images129. 
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2.5 METHODOLOGY: ADDITIONAL DETAILS 
2.5.1 Recruitment  
(See Refs58,130–132) 
These studies form part of a larger cohort study investigating the effects of alcohol and 
methamphetamine consumption during pregnancy. The women whose infants were 
investigated were recruited from 3 midwife obstetric units located in the Cape Coloured 
communities in Cape Town. Following their first antenatal visit to the clinic (at approximately 
20 weeks gestational age), the women were interviewed about their alcohol and drug use, at 
recruitment and at time of conception. The interviewer used a time-line follow-back approach 
to determine alcohol consumption and patterns (see below). Women who reported drinking at 
least 1.0 oz absolute alcohol/ day (AA/d; approximately 2 standard drinks) or who participated 
in binge drinking (≥ 2.0 oz AA/ occasion) were invited to join the study. Women who did not 
drink or drank < 1.0 oz AA/d and did not binge drink were invited to join the study as control 
subjects. Women from the same community who used methamphetamine but reported minimal 
alcohol use (with the same criteria as for the controls), were invited to participate in the 
methamphetamine group. Exclusion criteria for the mothers in the study were as follows: age 
< 18 years old, multiple pregnancy, HIV+ status, and on medication for diabetes, epilepsy, 
hypertension and/ or cardiac illness. For the infants, the exclusion criteria were neural tube 
defects, seizures and chromosomal abnormalities. Women who reported drinking during 
pregnancy were counselled to stop drinking or to reduce their alcohol intake; those who agreed 
were referred for treatment. 
2.5.1i Timeline follow-back  
The first time-line follow-back interview was conducted at recruitment. The women were asked 
about their drinking during each day in a typical 2-week period around the conception date, 
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using specific daily activities and times to assist recall. If a woman’s drinking patterns or 
quantity had changed during the pregnancy, the same process was followed regarding the 
previous two weeks and when the change had occurred. Two further interviews were 
performed, at approximately 4 and 12 weeks post-recruitment, where the follow-back approach 
was used to assess her alcohol, drug use and cigarette smoking for the previous two weeks, as 
well as for any weeks where she had consumed more alcohol than usual. Volume was recorded 
for each type of alcohol being consumed (wine, beer, liquor, cider) and converted to oz AA, to 
produce 3 measures of alcohol consumption across pregnancy: oz AA per day, oz AA per 
occasion, and frequency of drinking. Methamphetamine was recorded as number of days used 
per month of pregnancy. Smoking was recorded as cigarettes smoked per day. Other drugs of 
abuse (marijuana, cocaine, and methaqualone) were measured as number of days used/ month. 
To confirm the maternal report, urine samples were collected from a subset of the women and 
tested with the AccuTestTM 6+2 drugs of abuse panel test (DTA Pty Ltd, Cape Town, South 
Africa), which measures drug metabolites of amphetamines, opiates, tetrahydrocannabinol, 
cocaine and methaqualone). Of the women who reported no methamphetamine use, none tested 
positive for methamphetamine. None of the women tested positive for cocaine or opiates. 
 
2.5.2 Post-processing and manual segmentation of anatomical scans 
(See Refs133) 
2.5.2i Post-processing of anatomical MRI with FreeSurfer 
Two acquisitions of a motion navigated multiecho gradient echo sequence were used for the 
volumetric study, with flip angles of 5° and 20° respectively. Using FreeSurfer 
(http://surfer.nmr.mgh.harvard.edu/), a composite image was then synthesised from the two 
with an optimised flip angle for contrast. Each image was converted from dicom format to mgz 
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format using mri_convert. The 8 echoes from each were then split by selecting successive 
frames. Tissue parameters were estimated using mri_ms_fitparms, which takes all echoes from 
both acquisitions, estimates the T1 and PD values for each voxel, and creates T1 and PD 
volumes. Using mri_synthesize, these were then used to synthesize an optimally weighted 
volume with TR = 20ms, flip angle = 24° and TE 0ms. 
2.5.2ii Manual segmentation using Freeview software 
Freeview is a visualisation tool forming part of the FreeSurfer software package (FreeSurfer 
image analysis suite http://surfer.nmr.mgh.harvard.edu/). It is used to visualise and analyse 
anatomical images in three planes (sagittal, coronal and axial). For manual segmentation, the 
anatomical scan is opened and size, contrast and brightness are adjusted for optimal 
visualisation of ROIs. A new volume is then created to layer over the original. Each volume 
can be viewed in a range of colour maps; for manual tracing purposes, the original volume is 
viewed in greyscale (i.e. a standard anatomical MRI view), while the segmentation volume is 
viewed in colour. Freeview assigns each ROI a unique colour to assist in easy identification 
and visualisation of individual structures. Each ROI is additionally assigned a unique integer 
value for later analysis. The opacity of the segmentation volume can be adjusted for optimised 
viewing of the underlying structures. Each volume view can be “smoothed” for more 
anatomical realism; for the purposes of this study, the original volume was smoothed, while 
the segmentation volume was not. 
Manual segmentation was performed with a stylus on a Lenovo ThinkPad X220 tablet. Using 
the Freehand tool in Freeview, an outline of each ROI was created in the segmentation volume 
on a slice by slice basis. This was then filled using the Fill tool. Regions were traced in the 
following order: caudate nucleus, putamen and globus pallidus, nucleus accumbens, thalamus, 
hippocampus and amygdala, vermis, and cerebellar hemispheres. Where structures are 
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bilateral, both hemispheres were completed for that structure before the next was traced. Voxels 
traced in one plane in Freeview are automatically visible in all three; tracings were completed 
chiefly in the coronal plane, with guidance from the sagittal and axial planes where necessary. 
Caudate nucleus and nucleus accumbens 
An oblique line from the inferior tip of the lateral ventricle to the midpoint of the inferior 
boundary of the internal capsule was drawn to separate the caudate and nucleus accumbens, 
while a line descending from the middle of the inferior border of the anterior limb of the internal 
capsule was considered to define the boundary between the putamen and the nucleus 
accumbens. The caudate and accumbens were traced as one structure and separated later. 
Posteriorly, the caudate diminishes in size and eventually becomes difficult to define as the tail 
reaches the point where it curves inferiorly posterior to the thalamus. For this reason the 
posterior and inferior portions of the caudate were not traced.  
Putamen 
The junction of putamen and pallidum was generally most clearly seen in axial sections, so that 
tracing was done in the axial or coronal planes on a slice by slice basis. 
Pallidum 
The pallidum was traced by the addition of its inferior border to the tracing of the putamen in 
each slice. Globus pallidus externa and interna were indistinguishable from one another and so 
were not separated.  
Thalamus 
The thalamus lies medial to the posterior limb of the internal capsule. Its medial and superior 
borders are visible where the thalamus meets the cerebrospinal fluid of the lateral and third 
ventricles or within the horizontal fissure superiorly. Where the left and right thalami meet in 
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the midline, they were separated by an appropriate line in the median sagittal plane. The lateral 
border of the thalamus is formed by the medial boundary of the internal capsule. Inferiorly, it 
is bounded by the subthalamus, with the medial lemniscus between the two structures. In 
posterior slices the internal capsule disappears and the thalamus descends to form the medial 
and lateral geniculate bodies. 
Hippocampus 
The hippocampus was traced chiefly in the coronal plane, with considerable guidance from 
views in the sagittal plane. It can be seen in sagittal sections within the temporal lobe as a 
sausage-shaped structure. More anteriorly in the coronal plane the hippocampal head appears, 
and the structure becomes large and rounded.  
Amygdala 
The amygdala is located anterior to the head of the hippocampus. It is bounded in its anterior, 
inferior and lateral aspects by white matter, and postero-inferiorly by the hippocampus and the 
tip of the lateral ventricle. The tracings of the amygdala were done in all three planes, as it was 
difficult to see in its entirety in any one plane. The amygdala is difficult to define clearly, which 
may reflect on the reliability of the tracing volumes generated. 
Cerebellum and Vermis 
The cerebellar hemispheres were primarily traced in sagittal and coronal planes.  The two 
hemispheres are anatomically separated by the vermis. In the coronal and axial planes, the 
vermis is distinguished from the hemispheres by means of vertical lines which taper slightly 
posteriorly (in the axial plane) and inferiorly (in the coronal). By convention of the Infant Brain 
Segmentation Manual (see Ref134), the vermis is present in no more than five slices in and 
adjacent to the midline in the sagittal view. Once the vermis was delineated, the hemispheres 
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were traced. In the infant brain, subdivision of the hemispheres into lobules is very difficult 
and so was not attempted in this study. 
2.5.2iii Determinations of volumes and interrater reliability 
To compute the volumes of the segmented structures, compute_label_volumes.csh in 
FreeSurfer was used. This script produced an output of voxel count and volume (mm3) for each 
structure.  
For interrater reliability, 9 of the brains were also segmented by an independent, trained 
investigator. The degree of overlap was determined using compute_interrater_variability in 
FreeSurfer. The Dice overlap measure was used, which is defined as follows: 
Dice = 2*nshared/(nvox1+nvox2) where  
nshared = intersection of the 2 ROIs 
nvox1 = number of voxels in ROI1 
nvox2 = number of voxels in ROI2 
Dice coefficients were determined for each ROI as well as for the entire segmentation. 
 
2.5.3 Pre-processing of Diffusion Tensor images 
2.5.3i Data processing  
(See Refs118,135–138) 
Artefacts in diffusion weighted images have a considerable impact on the accuracy of the data 
obtained. A significant aspect of data processing prior to tractographic analysis is removal of 
such artefacts. Subject motion is almost inevitable in neonatal studies; to an extent, this can be 
managed by applying diffusion weighting gradients along more than 6 directions to create a 
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degree of redundancy, and discarding individual volumes in which motion is detectable. This 
is done manually as a first step in data processing. There is a limit to how many volumes can 
be discarded, however. In the current study, 30 diffusion-weighted (DW) volumes (or 
directions) were acquired, in addition to the non-weighted volumes. Any subject in which fewer 
than 12 volumes remained was discarded. Eddy currents are another source of artefact, and 
arise when the gradients are rapidly switched on and off. These, and more subtle motion 
artefacts, are corrected by applying affine registration to the b = 0 reference images, using the 
fsl tool eddy_correct. In the current study, 4 b = 0 images were acquired, and the DW images 
were registered to the mean of these. Susceptibility distortion is an additional problem. The 
ability of a substance to be magnetised when placed in an external magnetic field is termed 
magnetic susceptibility. Different substances have different susceptibilities, and in MRI these 
differences can produce artefacts at interfaces between such substances, such as between tissue 
and air. Echo planar imaging (EPI), which is typically used in DTI, is particularly sensitive to 
susceptibility distortion. This issue can be overcome by performing two DTI acquisitions with 
the phase-encoding gradient directions switched (anterior to posterior, and posterior to anterior, 
respectively). These images will have nearly identical distortions along the anterior-posterior 
axis but in opposite directions, and can thus be combined to produce a DT map in which the 
distortion is reduced. This is done using the topup tool in fsl, which estimates the field that 
most accurately represents both volumes. It is worth noting that, in practice, these distortions 
often occur simultaneously to some degree. Therefore, while the application of the various 
“correction” techniques can greatly reduce their effects, they can never fully be removed from 
the data.  
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2.5.3ii Mini-probabilistic tractography 
(See Ref135) 
In order to perform tractographic analysis, seed and target ROIs must be placed in appropriate 
locations with white matter connections. To determine these locations, a mini-probabilistic 
approach was used to highlight regions within the three networks of interest: commissural, 
projection and association. Mini-probabilistic tractography combines the valuable aspects of 
both deterministic and probabilistic tractography; it incorporates the uncertainty of the 
probabilistic algorithm, but is faster and generates tract structure, in line with the deterministic 
approach. A small number of brute force, whole brain tractography iterations are performed, 
each time perturbing the tensor properties based on their uncertainties as estimated during the 
previous iteration. The current study used FATCAT software in AFNI for this purpose127. Once 
the whole-brain tractography had been performed, a primary target ROI was placed within a 
central network of interest, followed by the placement of additional targets in locations along 
the tracts passing through the primary target region. 
2.5.3iii Tractographic propagation: FACTID 
(See Ref139) 
Propagation of tracts in tractography may be accomplished via a number of algorithms. One 
such technique is FACT (fiber assessment by continuous tracking)140. In this approach, test 
tracts initiate at each location where FA is greater than a given threshold (in adults, FA > 0.2 
is predominantly used), and each tract propagates in the 'forward' and 'negative' direction of the 
direction of the voxel's greatest diffusion (see Fig. 2.10A).  Upon reaching the edge of a voxel, 
the tract terminates if the FA in the new voxel is sub-threshold or if the turning angle of 
propagation is too large (this parameter is set to minimize the existence of tracts with extremely 
sharp bends that are deemed unphysical; for studies at standard voxel resolution of approx. 2 
mm isotropic voxels, this parameter is commonly in the range 45-60°); otherwise, the test tract  
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Figure 2.10. A. An example of the propagation of test tracks in two dimensional FACT, where tracks 
cross from edge to edge of the lower left voxel and pass to face-wise neighbouring voxels. B. The same 
test tracks in the FACTID approach, where tracks can propagate to the octagon surface in each voxel 
(the gray areas). Bold arrows represent the orientations of principal eigenvectors. (Adapted from Ref139). 
 
propagates by passing into the new voxel and being redirected to follow a trajectory parallel to 
its direction of greatest diffusion.  It is important to highlight that in this approach, tract 
propagation to a neighbouring voxel can only occur through  voxel ‘faces’; this means that a 
tract traversing the voxel diagonally through a voxel matrix may often be diverted from its 
underlying trajectory due to the neighbourhood definitions of the voxels. Additionally, rotation 
of either the coordinates or the tensor ellipsoids will have a significant effect on the output of 
the propagation algorithm, as a slight perturbation of direction could result in tract propagation 
orthogonal to the anatomical direction.  
While the FACT approach has been shown to reproduce several known, major tract bundles 
reliably across populations, the FACTID (fiber assessment by continuous tracking including 
diagonals) was developed to address the aforementioned issues of potential grid-neighbour bias 
by permitting tracts to propagate diagonally between voxels (see Fig. 2.10B). Thus instead of 
tracts only propagating through six boundary faces, they may propagate through any of the 26 
neighbouring voxels that share either a face, edge or node.  Tracts reaching a voxel boundary 
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near an edge or corner 'test propagate' to determine whether their trajectory carries through a 
corner, edge-region or voxel face. A tract passing through a voxel diagonally is now able to 
follow its trajectory through successive voxels. FACTID has been shown to provide more 
reproducible results than FACT when data are acquired on rotated grids or as signal-to-noise 
ratio (SNR) is decreased, and results of the former converge to high-resolution values more 
quickly than FACT. Thus, the simple change in FACTID produces more robust results. 
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PRENATAL METHAMPHETAMINE EXPOSURE IS ASSOCIATED 
WITH REDUCED CAUDATE VOLUMES IN NEONATES 
3.1 INTRODUCTION 
Methamphetamine is one of the most widely used recreational drugs65 and there is considerable 
evidence that exposure during pregnancy has marked effects on the infant58–60,141,142. Given the 
dopaminergic activity of methamphetamine and its documented neurotoxicity in adult 
users88,93, it was expected that prenatal exposure would induce similar damaging effects on the 
infants concerned, considering the rapid development and growth of the CNS that occurs 
during this period72. Neuropsychological and behavioural alterations have been observed in 
studies of children with prenatal methamphetamine exposure, including low arousal and 
lethargy67,68, poor fine motor skills75, poor psychomotor and emotional adjustment76 and 
aggressive behaviour77. Deficits in visuomotor integration88, inhibitory control84, and executive 
function and working memory81 have also been observed in children with in utero 
methamphetamine exposure. In view of these findings, it is of interest to determine whether 
these deficits reflect structural alterations in the brain related to prenatal methamphetamine 
exposure, and whether these alterations can already be detected in the newborn. 
MRS, DTI and fMRI have shown a range of metabolic, microstructural and functional 
alterations as a consequence of prenatal methamphetamine exposure82,86–89,91,92,143. In children 
with prenatal methamphetamine and alcohol exposure, reductions in volume in the thalamus, 
striatum, and left parieto-occipital and right anterior prefrontal cortices, and increased volumes 
of several cortical regions, were observed compared to controls and to children with alcohol 
exposure only93. Putamen and globus pallidus volumes were reduced in methamphetamine 
exposed children, with a trend towards volume reductions of the caudate, thalamus, 
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hippocampus and cerebellum94. A number of these reductions were related to poorer cognitive 
function94. 
Prenatal methamphetamine exposure has been shown to have considerable, persistent effects 
on dopaminergic regions of the brain such as the fronto-striatal circuits, as well as certain non-
dopaminergic regions. The neuroimaging literature, however, is sparse. To date, no anatomical 
studies have been conducted with neonates. Such an investigation in neonates is highly 
warranted, not least because of the sub-optimal postnatal environment into which these children 
are often born59,60,65,81. The aim of this study was thus to investigate the volumetric changes in 
subcortical areas and cerebellum of the brains of neonates with prenatal methamphetamine 
exposure. We hypothesized that increased exposure to methamphetamine would be associated 
with reduced volume of the striatal structures. 
 
3.2 METHODS 
3.2.1 Study sample 
The cohort consisted of 39 infants born to women in the Cape Coloured (mixed ancestry) 
community of Cape Town, South Africa, who are participating in a larger prospective 
longitudinal study of prenatal alcohol and drug exposure on infant development58,132,135. The 
rate of methamphetamine abuse in this community is the highest in South Africa3, with 35-
43% of drug treatment patients reporting it as their primary drug of abuse7,144. Rates of use 
among women in this community have been reported to be as high as 58%55. 
Pregnant mothers were recruited following initial antenatal care visits at midwife obstetric care 
units serving the community. The mothers were interviewed, once at recruitment and twice 
more before delivery, regarding their alcohol consumption using a time-line follow-back 
approach130,131, and about the frequency of use (days per month) of methamphetamine, 
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cigarettes and other drugs (marijuana, methaqualone, and cocaine) during pregnancy. The 
present study consists of infants born to women in the cohort who reported using 
methamphetamine at least twice per month during pregnancy. The control group, recruited 
from the same community, comprises infants whose mothers abstained from alcohol and other 
drugs of abuse or who consumed no more than 2 drinks on 2 or fewer occasions during 
pregnancy. Exclusion criteria for pregnant women were as follows: < 18 years of age, HIV 
positive, treatment for medical conditions such as hypertension, epilepsy, diabetes or heart 
disease, and multiple pregnancy. Infant exclusion criteria were neural tube defects, major 
chromosomal anomalies, very low birth weight (< 1500g), gestational age < 32 weeks, and 
seizures58. Urine samples were collected and tested to confirm the validity of drug use (reported 
elsewhere as part of the larger cohort study58). 
Informed consent was obtained from each mother at recruitment and at the Child Development 
Research Laboratory and neuroimaging visits. Approval for this study was obtained from the 
ethics committees at Wayne State University and the Faculty of Health Sciences at the 
University of Cape Town. 
 
3.2.2 Scanning 
Nonsedated infants were scanned between 1 and 4 weeks after birth, with the exception of two 
infants born prior to 34 weeks who were scanned at 7 and 9 weeks of age, respectively.  
Infants were brought to the Cape Universities Brain Imaging Centre (CUBIC) a minimum of 1 
hour prior to scanning. During this period they were weighed and head circumference and 
crown-to-heel length were measured. Neonatal behavioural characteristics145 were assessed by 
a trained developmental paediatrician. Following this, the infant was swaddled firmly and 
placed in a VacFix® vacuum cushion (S&S Par Scientific, Houston, TX) for later use in 
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immobilising the infant’s head in the coil, in accordance with an adapted protocol for 
neuroimaging assessment of nonsedated newborns146. Earplugs were used to protect the infant 
from the noise of the scanner. The infant was then fed by the mother and allowed to fall asleep. 
MRI scanning was performed using a Siemens 3 T Allegra scanner. A custom-built circularly 
polarised birdcage coil, designed for use with neonates, was used for transmission and 
reception of the signal. Several sequences were acquired during the protocol. For this study a 
motion navigated multiecho gradient echo sequence was used, with the following protocol 
parameters: FOV 114 mm, 128 slices, TR 20 ms, TE 1.46/ 3.14/ 4.82/ 6.5/ 8.18/ 9.86/ 11.54/ 
13.22 ms, 1 mm3 isotropic resolution. The sequence was acquired twice, with flip angles of 5° 
and 20°, respectively. 
The sleeping infant was positioned in the scanner and immobilised by means of the VacFix® 
cushion. An oxygen saturation and pulse monitor probe was secured to the infant’s foot, and 
this was monitored during the scanning period. 
 
3.2.3 Data synthesis 
The individual echoes from the two flip angle acquisitions were split, tissue parameters 
estimated and an image volume synthesised using FreeSurfer147. A flip angle of 24° was chosen 
as that which produced optimal contrast. 
 
3.2.4 Manual segmentation  
ROIs were viewed and manually delineated using Freeview software (FreeSurfer image 
analysis suite http://surfer.nmr.mgh.harvard.edu/) run on a Lenovo ThinkPad X220 tablet. The 
following structures were traced bilaterally: caudate nucleus, nucleus accumbens, putamen, 
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pallidum, thalamus, hippocampus, amygdala and cerebellar hemispheres, as well as the 
cerebellar vermis. Tracing protocols for each section followed the Infant Brain Segmentation 
Manual developed by the HST/MGH Athinoula A. Martinos Center for Biomedical Imaging134, 
where training in the use of Freeview software and manual tracing of infant MRI scans was 
received.  Tracings were rendered chiefly in the coronal plane, with guidance from the axial 
and sagittal planes where region boundaries were indistinct in a coronal view. The volumes of 
the traced regions were then calculated. Total brain volume was determined by extracting the 
brain from the anatomical T1-weighted volumes using an in-house script. Nine brains were 
independently retraced for inter-rater reliability purposes. Both tracers were blind to the 
exposure status of the infant brains. 
 
3.2.5 Statistical analysis 
Statistical analysis was performed using SPSS (version 22; IBM, Armonk, NY). Nine variables 
were considered as potential confounders: maternal age at delivery, educational status (number 
of years), parity, maternal marijuana use (days per month during pregnancy), smoking (number 
of cigarettes per day during pregnancy), alcohol use (oz of absolute alcohol consumed per day 
during pregnancy), infant sex and gestational age at scan (weeks), and total brain volume.  
T-tests or chi-square tests for categorical variables were used to compare sample characteristics 
between exposed and control groups. The methamphetamine use and smoking variables both 
contained outliers, which were recoded to 1 unit greater than the next highest value (see148). 
Prenatal alcohol use was skewed and was therefore logged for multivariable analyses.   
Pearson correlation was used to analyse the relation between methamphetamine exposure and 
ROI volume. Following this, regions showing significant association with methamphetamine 
exposure were analysed by means of hierarchical multiple linear regression using a best 
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estimate approach. Methamphetamine was entered first into the regression; the potential 
confounders described above which were at least weakly related to volume (p < 0.20) were 
then entered successively according to the strength of their association with the ROI volume. 
Variables that did not alter β by 10% or more were excluded.  
 
3.3 RESULTS 
3.3.1 Sample characteristics 
Data is reported for 39 infants (18 methamphetamine exposed and 21 controls). Demographic 
and substance exposure characteristics of the infants are summarised in Table 3.1. Maternal 
education differed between groups, with controls achieving a higher level of education than the 
methamphetamine group.  
The sample consisted of 18 male and 21 female infants. Infants exposed to methamphetamine 
were born earlier, which is consistent with previous studies58,141. Although the 
methamphetamine group weighed less at birth, there was no between-group difference in terms 
of gestational age at scan (calculated as gestational age at birth + age in weeks). 
Mean methamphetamine, smoking, marijuana and alcohol use by mothers of the exposed group 
was higher than in the control group. Although control mothers did not use methamphetamine, 
62% reported smoking, 9.5% used marijuana and 4.8% (1 mother) drank alcohol, although this 
was within the acceptable limits set for inclusion in the cohort. By contrast, all of the mothers 
in the exposed group reported smoking, 55.6% (n = 10) reported using marijuana and 55.6% 
(n = 10) reported drinking alcohol during pregnancy.
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Table 3.1. Sample characteristics (N = 39) 
    Methamphetamine       Control       
          (n= 18)    (n = 21)    
 Mean SD Range  Mean SD Range χ2 or t p 
Maternal                   
Age at delivery (years) 27.0 4.2 19.8 - 34.0  26.7 5.9 18.8 - 36.4 -0.19 0.850 
Education (years) 9.3 1.4 7.0 - 12.0  10.5 1.4 7.0 - 12.0 2.60 0.013 
Parity 2.2 1.6 0 - 5  1.4 1.3 0 - 4 -1.70 0.098 
Socioeconomic statusa 20.2 4.7 11.0 – 27.0  22.1 7.2 8.0 – 34.5 0.96 0.342 
Infant          
Sex (% male) 33    57   2.21 0.137 
Birth weight (g) 2804.2 498.9 1370.0 - 3590.0   2915.7 541.7 1940.0 - 4200.0 0.67 0.510 
Head circumference (cm) 32.9 1.9 27.0 – 35.0  33.3 2.0 31.0 – 38.0 0.67 0.509 
Crown-to-heel length (cm)b 47.6 3.5 41.0 – 53.0  48.8 3.4 40.0 – 53.0 1.08 0.287 
Gestational age at birth (weeks) 37.6 2.7 31.0 - 41.3  39.1 2.0 33.7 - 42.1 2.01 0.052 
Gestational age at scan (weeks) 40.5 2.1 36.7 - 44.0  41.6 1.9 37.6 - 44.6 1.65 0.107 
Total intracranial volume (mm3) 491044 41631 395900 - 549600  516805 69236 428700 - 660700 1.38 0.177 
Substance use          
Methamphetamine (days/month) 6.1 3.8 0.7 - 12.0  0.0 0.0 0.0 - 0.0 -7.34 <0.001 
Smoking (number cigarettes/day) 6.5c 4.5 2.0 - 20.0  3.5
d 3.4 0.0 - 10.3 -2.42 0.021 
Marijuana (days/month)  5.8e 8.4 0.0 - 30.5   0.0
f 0.1 0.0 - 0.2 -3.18 0.003 
Alcohol (oz AA /day)  0.2g 0.4 0.0 - 1.4    0.0h 0.0 0.0 - 0.1 -2.15 0.038 
          
aHollingshead (2011) Four Factor Index of Social Status Scale;   bn = 17 for methamphetamine group; c18/18 (100%) and d13/21 (62%) smoked;  e10/18 (56%) and f2/21 
(10%) used marijuana; g10/18 (56%) and h1/21 (5%) used alcohol. 
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Table 3.2. Volumes and interrater reliability measures 
ROI Volume (mm3) Dice Coefficients 
 
Methamphetamine 
(n=18) 
Mean ± SD 
Control  
(n=21) 
Mean ± SD 
Median Range 
Overall - - 88.5 84.7 - 99.6 
Left caudate 1241 ± 201 1300 ± 197 84.6 83.2 - 88.8 
Right caudate 1175 ± 159 1264 ± 156 86.6 84.4 - 89.9 
Left putamen 1679 ± 256 1806 ± 322 81.5 76.7 - 87.3 
Right putamen 1720 ± 242 1798 ± 328 84.0 73.2 - 86.5 
Left pallidum 650 ± 111 685 ± 123 66.8 37.7 - 76.1 
Right pallidum 594 ± 91 626 ± 131 69.8 49.8 - 81.1 
Left nucleus accumbens 150 ± 29 148 ± 41 38.3 18.0 - 63.4 
Right nucleus accumbens 158 ± 41 147 ± 41 43.1 28.1 - 66.2 
Left thalamus 4344 ± 352 4435 ± 713 90.3 85.3 - 92.1 
Right thalamus 4264 ± 360 4470 ± 708 90.8 86.4 - 92.9 
Left hippocampus 1187 ± 148 1149 ± 151 80.8 63.2 - 85.1 
Right hippocampus 1173 ± 109 1144 ± 140 79.7 73.4 - 86.3 
Left amygdala 383 ± 116 370 ± 74 64.2 44.6 - 75.6 
Right amygdala 406 ± 124 374 ± 79 67.5 54.0 - 74.5 
Vermis 1957 ± 383 1986 ± 386 84.7 71.4 - 89.7 
Left cerebellar cortex 10207 ± 1500 10365 ± 1949 92.4 91.7 - 96.0 
Right cerebellar cortex 10188 ± 1447 10501 ± 1820 93.3 88.6 - 95.8 
      
 
3.3.2 Inter-rater reliability of manual tracing 
Volumes of traced regions and inter-rater reliability measures are reported in Table 3.2. 
Interrater reliabilities are reported as the median and range of the Dice coefficients calculated 
for 9 brains. A threshold median value of 75.0 was set, falling below which any traced region 
was regarded as too unreliable to include in further analyses. Following these criteria, right and 
left pallidum, right and left nucleus accumbens, and right and left amygdala were discarded 
from further analyses.  
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Table 3.3. Association between prenatal methamphetamine exposure and volume of subcortical 
structures (N = 39) 
Volume (ROI) Methamphetamine exposure 
  r p 
Left caudate  -0.31  0.059 
Right caudate  -0.48  0.002 
Left putamen -0.13 0.430 
Right putamen -0.10 0.550 
Left thalamus -0.17 0.297 
Right thalamus -0.26 0.107 
Left hippocampus -0.06 0.702 
Right hippocampus 0.10 0.563 
Vermis -0.07 0.654 
Left cerebellum -0.18 0.275 
Right cerebellum -0.22 0.188 
   
r is the Pearson correlation between methamphetamine exposure and volume. Boldface denotes significant 
findings. 
 
 
3.3.3 Relation of methamphetamine exposure to subcortical regional volumes  
The associations between methamphetamine exposure and the subcortical regions are shown 
in Table 3.3. Pearson correlation analyses showed that heavier methamphetamine exposure was 
associated with reduced left and right caudate volumes (Fig. 3.1). No association was observed 
between methamphetamine exposure and the other regions. Infants with heavier 
methamphetamine exposure also tended to have reduced total brain volume (r = -0.28, p = 
0.08). 
Potential confounding variables (Table 3.4) were included in the subsequent regression 
analyses if they showed a correlation with ROI volume at p < 0.20. Total brain volume, 
cigarette smoking, infant sex, gestational age at time of scan, and parity were associated with 
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Figure 3.1 Relation of prenatal methamphetamine exposure across pregnancy to volume of the right 
caudate nucleus. 
 
left and right caudate volumes, while maternal education was also associated with right caudate 
volume. Left and right caudate volume were then each regressed with methamphetamine, 
followed by total brain volume, and finally maternal cigarette smoking and infant sex for left 
and right caudate volumes respectively. Prenatal exposure to methamphetamine was associated 
with reduced volume in the right caudate even after controlling for total brain volume (β = -
0.33, p = 0.01) and the potential confounder (infant sex; β = -0.28, p = 0.03). The association 
of methamphetamine exposure with left caudate volume did not persist when total brain volume 
and maternal smoking were included (β = -0.07; p < 0.20).  
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Table 3.4. Association of potential confounding variables with volumes of regions showing significant associations with methamphetamine 
  
Maternal 
age 
(years) 
Education 
(years)  
Parity 
Marijuana 
(days/month) 
Smoking 
(number 
of 
cigarettes/ 
day) 
Alcohol 
(oz 
AA/day) 
Infant sex 
Gestational 
age at scan 
(weeks) 
Total 
brain 
volume 
(mm3) 
Left caudate -0.03   0.21   -0.24   -0.02 -0.49   0.16 -0.42   0.25   0.55  
 (0.840) (0.208) (0.145) (0.898) (0.002) (0.337) (0.008) (0.128) (<0.001) 
Right caudate -0.18   0.24   -0.35   0.02 -0.37   0.19 -0.49   0.43   0.59  
 (0.271) (0.170) (0.032) (0.924) (0.020) (0.237) (0.002) (0.006) (<0.001) 
          
Values are Pearson r (p). Results with a trend towards association (p < 0.20) are shown in boldface.  
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3.4 DISCUSSION 
This study is the first to investigate the neurostructural effects of prenatal exposure to 
methamphetamine in neonates. As hypothesised, changes were observed in the left and right 
caudate nuclei, as well as in total brain volume, with reduced volume observed in all three as a 
consequence of prenatal methamphetamine exposure. Although the association in the left 
caudate did not persist when confounding variables were included in the analysis, the effect of 
methamphetamine on the right caudate remained significant, even after controlling for 
reduction in total brain size. 
These results are consistent with those obtained in previous studies in which volumetric effects 
of prenatal methamphetamine exposure on the caudate were observed in older cohorts. In a 
study of children aged between 5 and 15 years, the striatum was smaller in children exposed to 
both methamphetamine and alcohol prenatally, with the volume reduction more severe than in 
children exposed to alcohol alone93. Similarly, a study of 3-5 year old children with 
methamphetamine and tobacco exposure showed significantly reduced caudate volume 
following control for tobacco exposure95. A  trend towards reduction in volume was observed 
in the caudates of children aged 3-16 years with prenatal methamphetamine exposure94. In an 
investigation of children aged 8-11 years with multiple substance exposure, including 
methamphetamine, a trend towards reduced caudate volume was observed, with significantly 
decreased total volume149. By contrast, increased striatal volume was found in 6-year-olds with 
in utero methamphetamine exposure, findings which may reflect methodological effects96. This 
was one of only two studies that performed automated segmentation using FreeSurfer, but 
Derauf and colleagues, who noted reduced caudate volume, made use of a validated pediatric 
atlas95, while Roos et al96 do not specify which atlas was used for analysis. In adult users, 
volumetric alterations have been observed in a number of studies. A reduction in caudate 
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volume was noted in methamphetamine-dependent smokers20. Other research, however, 
observed increased caudate volume in recently abstinent methamphetamine users18,150.  
The loss of effect of methamphetamine in the left caudate after controlling for confounders was 
unexpected, but may be due to chance confounding in this sample. The association of 
methamphetamine with volume was weaker in the left caudate than in the right before the 
addition of the confounding variables, while the association of cigarette smoking with volume 
was considerably stronger in the left caudate than in the right. Given that the relative 
magnitudes of these effects might vary in different samples, it seems reasonable to suggest that 
both these exposures have bilateral impact. Cigarette smoking has been shown to be associated 
with volume reductions in a variety of brain structures in adult smokers151 and children with 
prenatal exposure152.  
Previous studies of prenatal methamphetamine exposure reported volume reductions in 
additional regions, including the hippocampus94 and thalamus93 as well as in a number of 
frontal cortical regions93. These alterations were not observed in the current study. It is worth 
noting that the strength of the association between methamphetamine and thalamus volume in 
this study might well have proved significant with a larger sample size; the same can be said 
of the association of methamphetamine exposure with cerebellar volumes. The strength of the 
association of methamphetamine with caudate volume in the current study, however, lends 
support to the hypothesis that prenatal methamphetamine specifically targets dopamine-rich 
regions, such as the caudate. This is in striking contrast to alcohol, which has been shown to 
be teratogenic to multiple regions of the brain153–156, and suggests that the mechanisms whereby 
methamphetamine and alcohol induce CNS damage are likely distinct from one another. 
Reduced total brain volume has been observed previously in children with prenatal 
methamphetamine exposure149. While this was also observed in the current study, the right 
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caudate was disproportionately affected, with the volume reduction in this structure remaining 
significant after adjusting for total brain volume. Reduced birth weight and lower gestational 
age at birth have also been shown to be associated with prenatal methamphetamine 
exposure63,74,141. This may be due to the vasoconstrictive effect of methamphetamine, causing 
reduced blood flow across the placenta57 and consequent restriction of nutrient and oxygen 
supply to the fetus65,94. Analysis of placental development in our cohort showed that 
methamphetamine use during pregnancy was associated with increased placental size, as well 
as increased placenta- to birth- weight ratio, lower gestational age at birth, and increased risk 
of intrauterine passing of meconium, which suggests that the exposed fetus may experience 
prolonged periods of hypoxia-ischemia58. 
The precise mechanisms whereby in utero methamphetamine exposure reduces caudate 
volume are not fully understood. Methamphetamine has been shown to be neurotoxic to 
dopaminergic and serotonergic axons and terminals in animal157–160 and human studies45,161, 
and in mature neurons appears to involve the production of reactive oxygen species (ROS), 
activation of P53 and subsequent apoptosis, and dysfunction of mitochondria162. Alterations in 
dopamine and dopamine metabolite concentrations have been observed in the striatum of rats 
prenatally exposed to methamphetamine163,164. Additionally, gene expression profiles are 
altered in rats with prenatal methamphetamine exposure, with substantial changes being 
observed in a number of genes coding for structural and guidance proteins which play vital 
roles in regulating normal neuronal development165. ROS production consequent to 
methamphetamine exposure in utero has been observed in animal studies166,167, although the 
mechanisms by which this induces damage in the developing nervous system appear to be 
different from those in mature neurons167. Methamphetamine exposure appears to have 
differential effects on dopamine neurons depending on the age at which exposure occurs168; in 
non-human primates in the second gestational trimester, neurons of the nigrostriatal pathway 
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have been shown to be particularly vulnerable to methamphetamine-induced damage168. 
During this period primate dopamine neurons undergo natural cell death as part of the normal 
development and maturation of the neuronal population169, and it has been hypothesised that 
this might render them more highly susceptible to damage168.  
To our knowledge, this is the first study in which reduction in caudate volume is demonstrated 
in neonates with prenatal methamphetamine exposure. Piper and colleagues have observed that 
children with prenatal methamphetamine exposure are very likely to be born into a poor 
postnatal environment81. Primary caregiver psychological symptoms and poor quality home 
environment were shown to increase behavioural problems assessed on the Child Behavior 
Checklist, in studies of preschool age children with prenatal methamphetamine exposure79,170. 
Neonatal evaluation of the effects of methamphetamine exposure allows for assessments 
relatively unconfounded by the effects of postnatal environment. Evaluation of 
methamphetamine exposure effects during the neonatal period allows for assessments of 
exposure prior to the effects of postnatal environment. This may also be a consideration in 
understanding why effects were observed in a greater number of regions in studies of prenatal 
methamphetamine exposure which used older cohorts. 
The women whose children were scanned in this study were recruited during pregnancy. This 
provided the advantage of allowing a more accurate measure of methamphetamine use by 
means of the timeline follow-back approach as described above. This is a distinct advantage 
over studies of older children in which recall of precise drug use by the mother is all but 
impossible, and it allows a more valid quantitative analysis of the effects of methamphetamine 
exposure. To our knowledge, this is the first study that shows an association between increasing 
methamphetamine exposure and reduced caudate volume rather than group differences as 
reported in previous research93,94,96,149.  
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An additional strength of this study is the use of manual tracing for segmentation of brain 
regions. Manual segmentation is regarded as the “gold standard” in volumetric analysis of brain 
structures171–173. Furthermore, automated segmentations of immature brains, such as those of 
infants and children, are likely to be inaccurate given that the atlases on which these methods 
are based are derived from adult brains. This is a particularly relevant issue when the subjects 
are neonates, as incomplete myelination of the neonatal brain97 presents a challenge in correctly 
identifying regions of interest. 
There are a number of limitations to this study. The greatest is the potential confounding effects 
of polysubstance exposure, with the methamphetamine-exposed infants also having higher 
exposure to alcohol, cigarette smoking and marijuana. This is, unfortunately, almost inevitable 
in studies of prenatal drug exposure82,93. These other exposures were, however, controlled in 
the multivariable analyses in this study.  Moreover, as mentioned above, recruitment during 
pregnancy allowed for a more accurate measure of substance use. Previous studies93,94,96 did 
not control for cigarette exposure, which was shown to be a significant confounding variable 
in the current study.  
It should be considered that some unexamined additional factor, such as malnutrition or 
deprivation, may have played a role in these findings. However, both exposed and control 
groups were recruited from the same community, and socioeconomic status174 did not differ 
between groups. Furthermore, neither birth weight nor crown-to-heel length, both of which 
might be considered measures of intrauterine nutritional status, was different between exposed 
and control children.  
The sample size was small, but comparable to other studies93,96 and sufficient to observe 
statistically significant effects. It is possible that with a larger cohort additional differences 
might have been significant. A potential concern, as in most such studies, is the issue of 
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multiple comparisons. Eleven ROIs were included in the final analysis. However, the 
association of methamphetamine with right caudate volume remained significant, prior to the 
addition of confounders, even after controlling for multiple comparisons. Furthermore, as 
mentioned previously, the significant exposure effect was predicted a priori and found 
precisely where it was expected, which provides additional support for its validity. 
Given the rapid and heterochronous nature of early brain growth175, regional volumes obtained 
in the first weeks of life are particularly challenging to measure. Segmentation of the newborn 
brain is more time-consuming due to lower contrast-to-noise ratio176. Although the brain stem 
and posterior limbs of the internal capsule are myelinated in the newborn with white to grey 
matter contrast that is similar to the adult brain, other regions are unmyelinated with the grey/ 
white contrast inverted in T1-weighted images relative to adult contrast101,177. Despite these 
difficulties, we were able to demonstrate reductions in caudate volume in methamphetamine-
exposed newborns, consistent with previously published research in older children.  These 
reductions are thus already detectable in exposed infants in the first month postpartum. Future 
research is warranted to examine whether reduced caudate in methamphetamine-exposed 
neonates is predictive of the cognitive, behavioural and affective impairments observed in older 
children. 
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CHAPTER 4 
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WHOLE-BRAIN WHITE MATTER CHANGES ARE ASSOCIATED 
WITH PRENATAL METHAMPHETAMINE EXPOSURE 
4.1 INTRODUCTION  
Methamphetamine abuse is one of the fastest growing drug problems worldwide, with 
estimates suggesting that its use may exceed the combined use of heroin and cocaine178. It 
functions primarily as a stimulant of the CNS, altering the release and activity of the 
neurotransmitters dopamine, norepinephrine and serotonin179–181. In current and abstinent 
users, it has been shown to be associated with damage in a range of brain areas. Changes in the 
striatum19,46,182, hippocampus23, amygdala46 and several cortical areas23,46,183 have been 
associated with methamphetamine abuse, with damage being seen to correlate with affective 
or cognitive alterations in a number of studies23,46,183,184.  
It has been estimated that over 5% of women in the United States have used methamphetamine 
while pregnant54. Methamphetamine has been shown to cause vasoconstriction and reduced 
blood flow to the placenta57; this has deleterious effects on the placenta itself58, and can result 
in fetal hypoxia67.  Methamphetamine use during pregnancy is associated with increased risk 
of hypertensive diseases of pregnancy142, increased risk of fetal and neonatal death142 and of 
preterm birth59,65,141, reduced birth weight141 and size142 and increased incidence of congenital 
abnormalities60,185. 
Given the demonstrated neurotoxicity of methamphetamine in adult users, it is to be expected 
that exposure during the vulnerable prenatal period would have severe and potentially long-
lasting effects on the infants concerned. The CNS undergoes rapid development and growth 
during gestation72 and it is reasonable to hypothesise that exposure to methamphetamine will 
produce significant neural modifications. 
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DTI provides a non-invasive means to visualise and characterise white matter120,125. It measures 
signal changes resulting from the diffusion of water molecules in the CNS and determines the 
various directionalities of this movement within fibre bundles, providing a number of measures 
of the structural integrity of the white matter and its component axons123. FA is the normalised 
standard deviation of the diffusivities parallel (AD) and perpendicular (RD) to the white matter 
fibres, and is the most widely-used DTI measure123. A high FA reflects diffusion that is chiefly 
parallel to the fibre bundles and restricted in the perpendicular direction, and is considered an 
indicator of more highly ordered, healthy or mature white matter125.  
In addition to the magnitude of the diffusivities, DT images contain information relating to the 
3-dimensional direction and alignment of diffusion123. This information can be used to map the 
trajectories of white matter bundles in the CNS120,123 by plotting fibre orientation from the 
directionality of sequential individual voxels125. The microstructure of these bundles, or of 
connections between defined regions of interest, can then be characterised by determining 
diffusion measures, such as FA, across the entire tract125. Alterations in diffusion characteristics 
are often related to functional changes186; many pathological processes induce changes in white 
matter microstructure, and DTI is thus a powerful tool for investigating the effects of these 
processes122. 
There is considerable evidence that methamphetamine induces alterations in white matter 
microstructure in adult users. Several studies have noted reduced FA in frontal regions of 
recently abstinent methamphetamine users28,31,187. Reduced FA in the CC, particularly in the 
genu, has also been observed in methamphetamine users29,30,187. Findings in the basal ganglia 
are more equivocal, with higher AD and RD observed in caudate and putamen in one study31, 
while another observed no changes in these structures188 relative to comparison subjects.  
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Given these findings in adult methamphetamine users, it is reasonable to hypothesise that in 
utero exposure to methamphetamine might have similar effects on the white matter of the 
exposed infants. The neuroimaging literature of children with prenatal methamphetamine 
exposure is sparse, however. In a study of children aged 6-7 years with prenatal 
methamphetamine exposure, reduced FA and higher RD, AD and MD were observed in tracts 
traversing striatal, limbic and frontal regions in comparison with control subjects82. Similarly, 
lower FA and increased AD and RD in the corona radiata were observed in infants exposed to 
methamphetamine and tobacco90. By contrast, higher FA was noted in the genu of the CC, the 
internal and external capsules and the corona radiata of 9-11 year old children with prenatal 
methamphetamine exposure92. Cloak and colleagues observed a similar trend in a voxel-based 
study of 3-4 year-olds with prenatal exposure, with lower diffusivity and higher FA in CC genu 
and splenium, frontal and parietal white matter, caudate, putamen, globus pallidus and 
thalamus91.  
The available literature thus demonstrates that prenatal methamphetamine exposure has 
significant and persistent effects on CNS microstructure, although the findings are not 
unanimous as to the exact direction of these changes. Further detailed investigations of white 
matter alterations associated with in utero methamphetamine exposure are highly warranted. 
Moreover, only one DTI study has to date been conducted with neonates, which investigated 
the combined effect of methamphetamine and tobacco exposure90. Investigations in neonates 
allow a greater separation of the effects of drug exposure from potential confounding post-natal 
influences. Given the sub-optimal environment into which children of mothers using 
methamphetamine are almost invariably born65,81, these are likely to exert a significant effect 
on neural development. 
The aim of this study was therefore to investigate the microstructural alterations, quantified by 
diffusion and anisotropy measures, in the three major classes of white matter tracts, 
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commissural, projection and association fibres, in the brains of neonates who had been exposed 
to methamphetamine prenatally, as compared to unexposed control infants from the same 
community.  
 
4.2 METHODS 
4.2.1 Study sample 
The study sample comprised infants who were born to mothers from the Cape Coloured (mixed 
ancestry) community of Cape Town, South Africa. The rate of methamphetamine abuse in this 
community is the highest in South Africa3; 35-43% of patients seeking treatment for drug abuse 
report it as their primary drug7,144. Rates of methamphetamine use have been reported to be as 
high as 58% among women in this community55. The infants are a subset of a larger prospective 
longitudinal study of prenatal alcohol and drug exposure on infant development58,132,135. The 
exposed group consisted of infants with prenatal exposure to methamphetamine, while the 
control group consisted of infants from the same community who had not been exposed to 
methamphetamine in utero, and with minimal or no prenatal exposure to alcohol or other drugs 
of abuse. 
Pregnant women were recruited following antenatal care visits at midwife obstetric care units 
in the community. They were interviewed at three time-points during pregnancy, once at 
recruitment, with regard to their methamphetamine, cigarette, alcohol and other drug use during 
pregnancy. The interviews used a timeline follow-back approach130,131. Women in the exposure 
group reported the use of methamphetamine on at least two occasions per month during 
pregnancy. Alcohol consumption, cigarette smoking and other drug use during pregnancy were 
recorded and controlled for in the later analyses. The control group consisted of women who 
abstained from methamphetamine, alcohol and other drugs of abuse, or who consumed no more 
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than 2 drinks on no more than 2 occasions during the pregnancy. Women were excluded if they 
met any of the following criteria: under 18 years of age, multiple pregnancy, HIV positive, or 
treatment for medical conditions such as hypertension, heart disease, epilepsy, or diabetes. 
Infant exclusion criteria were neural tube defects, seizures and chromosomal abnormalities58. 
Informed consent was obtained from each mother at recruitment and at the first laboratory visit. 
Ethics approval for the study was obtained from the ethics committee at Wayne State 
University and the Faculty of Health Sciences Human Research Ethics Committee at the 
University of Cape Town. 
 
4.2.2 Scanning 
Infants were scanned without sedation, at between 1 and 5 weeks of age, with the exception of 
1 infant who was born at 31 weeks gestational age and scanned at 9 weeks of age. Scanning 
took place at the Cape Universities Brain Imaging Centre (CUBIC) at the Faculty of Health 
Sciences campus of the University of Stellenbosch, South Africa. 
Infants were brought to the scanning facility at least 1 hour prior to scanning. Before scanning 
they were weighed, head circumference and crown-to-heel length were measured and neonatal 
behavioural characteristics145 were assessed. The infant was then swaddled and placed in a 
deflatable vacuum cushion (VacFix®, S&S Par Scientific, Houston, TX). Earplugs were 
inserted to protect the infant from the noise of the scanner. The infant was fed and allowed to 
fall asleep. 
The infant was placed in the scanner and immobilised by means of the VacFix® cushion, in 
accordance with a protocol developed by Laswad and colleagues146. A probe monitoring pulse 
and oxygen saturation was attached to the infant’s foot, and this was monitored throughout the 
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scanning process by a developmental paediatrician or research nurse who remained in the 
scanning room for the duration of the procedure. 
A Siemens 3T Allegra scanner was used for MRI scanning. A circularly polarised bird-cage 
coil, custom built for neonatal scanning, was used to transmit and receive the signal. Two 
diffusion weighted imaging (DWI) sets with opposite (AP/PA) phase encoding directions were 
acquired with a twice refocused spin echo EPI sequence. For 5 infants (1 exposed, 4 controls) 
the following scanning parameters were used:  TR 9500 ms, TE 86 ms, 50 slices of 80x80 
voxels (2x2x2 mm3). For the remaining infants a navigated DTI sequence was used, which 
performs real-time motion detection and correction189. The parameters in the latter sequence 
were identical to the first, with the exception of TR = 10 026 ms. In both sequences, AP and 
PA acquisitions each contained four b = 0 s.mm-2 reference scans and 30 DW gradient 
directions with b = 1000 s.mm-2. 
For anatomical imaging, a multiecho FLASH sequence190 was used, with protocol parameters 
as follows:  TR 20 ms, TE 1.46/ 3.14/ 4.82/ 6.5/ 8.18/ 9.86/ 11.54/ 13.22 ms, 128 x 144 x 144 
voxels, 1 mm isotropic resolution. Two anatomical acquisitions were obtained with flip angles 
of 5° and 20° respectively.  
 
4.2.3 Data processing and parameter estimation 
DWI data were inspected visually for motion and dropout slices, and individual volumes of 
poor quality were discarded. A minimum of 12 DWIs remained for each infant. Motion and 
EPI distortion were corrected in each set using FSL’s eddy_correct and topup tools137, and DTs 
and tensor parameters such as FA, MD, eigenvalues (Li, i = 1,2,3; AD = L1; RD = [L2+L3]/2) 
and directional eigenvectors (ei, i = 1,2,3) estimated using AFNI
191. Freesurfer software 
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Figure 4.1. Locations of target ROIs, with WM-ROI connections shown in top panel. Mini-probabilistic 
tractography was used to create homologous target locations, following which ROIs were mapped to 
each subject’s native DW space for tractography. A. Target ROIs for connections in the commissural 
network. B. The upper panel shows targets for right projection fibres in coronal view; the lower panel 
shows left and right projection targets in axial view. C. The upper panel shows targets for right 
association fibres in coronal view; the lower panel shows left and right association targets. (Figure 
reprinted from Ref135). 
 
(http://surfer.nmr.mgh.harvard.edu/) was used to generate optimised anatomical images from 
the FLASH sequences, and T1 and PD images were estimated.  
4.2.4 Selection of regions of interest and tractographic analysis 
Five white matter network groups were analysed: commissural fibres, which included the CC, 
projection fibres in left and right hemispheres, and association fibres in left and right 
hemispheres. These networks were defined by placing spherical target ROIs in one control 
brain (see Fig. 4.1). Twelve ROIs were placed along the extent of the CC and corona radiata. 
Eight ROIs were placed in the left projection fibres and 8 homotopically located ROIs in the 
right projection fibres. Ten ROIs were placed in the left association fibres, and 10 homotopic 
ROIs in the right association fibres. Sphere location was decided based on an initial estimate 
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of likely white matter bundle locations, using a “mini-probabilistic” tractographic approach 
which combined deterministic tractography and DT uncertainty measures135. Once ROIs had 
been placed in the initial subject, they were mapped to the full study cohort to produce in each 
subject five networks of homologous target ROI sets.  
Probabilistic tractography was then performed to find connections between ROIs in each 
network group and to determine quantitative measures of white matter properties in these 
connections. Using FATCAT software in AFNI127, uncertainties in DT eigenvectors and FA 
were estimated. The FACTID algorithm139 was then used to perform 5000 Monte Carlo 
iterations of brute force tractography. This algorithm finds fibres connecting pairs of targets at 
each iteration. The following propagation parameters were used: a maximum angle of 
propagation of 55°, between voxels with FA > 0.1, the standard FA threshold for white matter 
in infants192. All voxels through which a minimum (> 1% of Monte Carlo iterations) of tracts 
passed were included to define white matter regions of interest (WM-ROIs) associated with 
each pair of targets, and WM-ROIs found between the same target regions in every subject 
were included for further analysis. Mean and SD of the DTI parameters FA, AD, and RD were 
calculated for each WM-ROI. 
 
4.2.5 Statistical analysis 
Statistical analysis was performed using afex in R. SPSS (version 23; IBM, Armonk, NY) was 
used for analysis of demographic characteristics. Ten variables were considered as potential 
confounders: maternal marital status, parity, educational status (highest grade level completed) 
and socioeconomic status174 (ses), maternal marijuana use (days per month during pregnancy), 
maternal smoking (number of cigarettes per day during pregnancy) and maternal alcohol use 
(oz AA consumed per day during pregnancy), and infant sex, birth weight (grams) and 
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gestational age at scan (weeks). Data were examined for skewness and outliers were recoded 
to one unit greater than the next highest value (methamphetamine, alcohol, marijuana and 
cigarette smoking; see148). T-tests, or chi-squared tests for categorical variables, were used to 
compare sample characteristics between exposed and control groups. 
In each of the five WM networks, the association of prenatal methamphetamine exposure 
(number of days per month of pregnancy) with FA was examined. Acquisition sequence (DTI 
sequence used) was included in an initial multivariate general linear model analysis for each 
network. Potential confounding variables showing a weak association (p < 0.1) with FA were 
included in subsequent multiple linear regression analyses on a network-by-network basis. 
Following the network level analysis, the effect of methamphetamine exposure on each WM-
ROI in each network was analysed, with the significant confounding variables for each network 
included in the multiple regression. The primary aim of the post hoc evaluation was not to 
investigate individual connections, but to analyse global patterns of white matter disturbance 
within the networks examined. 
Potential associations of methamphetamine exposure with AD and RD were examined to 
determine whether significant associations of methamphetamine exposure on FA were related 
to either axial or radial diffusivity. Acquisition sequence was again included in an initial 
multivariate general linear model analysis for each network, followed by adjustment for the 
confounding variables used in the FA analysis. AD and RD in individual WM-ROIs were then 
analysed using the same procedure as described above.  
 
4.3 RESULTS 
4.3.1 Sample characteristics 
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The study sample consisted of 23 infants, 11 in the methamphetamine exposed group and 12 
in the control group. Table 4.1 shows the demographic characteristics of the cohort. Maternal 
education, measured as the highest grade level achieved by the mother, was significantly lower 
in the exposed group than the controls. 
The cohort included 12 male and 11 female infants, with the methamphetamine group including 
5 males and the control group including 7 males. The number of male and female infants per 
group was not statistically different between groups. Although methamphetamine exposed 
infants tended to be born at a younger gestational age, the difference was not significant. There 
was no difference between groups in gestational age at scan (gestational age at birth + age in 
weeks) or birthweight. 
Mothers of infants in the exposed group tended to smoke more than mothers of the control 
group. Control mothers did not use methamphetamine, but 67% smoked, 17% used marijuana 
and 1 mother drank alcohol within the acceptable limits set for inclusion in the cohort. By 
contrast, all of the mothers in the exposed group smoked cigarettes, 46% (n = 5) used marijuana 
and 46% drank alcohol during pregnancy. 
 
4.3.2 Tractographic connections 
Probabilistic tractography produced several WM-ROI connections between target ROIs that 
were common to all infants. In the commissural network, 3 connections were present in all 
infants. In the left and right projection fibre networks, 10 connections were present in each. In 
the left association fibre network, 12 connections were present, while in the right projection 
fibre network there were 9 connections common to all infants.
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Table 4.1. Sample characteristics (N=23). 
  
  
Methamphetamine (PEM) 
  
  
Control (Ctl) 
  
    
  (n= 11)    (n = 12)     
  Mean SD Range   Mean SD Range χ2 or t p 
Maternal                   
Age (years) 27.2 3.9 21.4 - 32.6  25.1 5.4 18.8 - 36.4 -1.05 0.305 
Education 9.4 1.2 7.0 - 11.0  10.6 1.1 9.0 - 12.0 2.56 0.018 
Parity 2.1 1.6 0 - 5  1.3 1.2 0 - 3 -1.44 0.165 
          
Infant          
Sex (% male) 45.5    58.3   0.38 0.537 
Birth weight (g) 2806.8 600.5 1370.0 - 3590.0  2795.8 485.2 1940.0 - 3470.0 -0.05 0.962 
Gestational age at birth (weeks) 37.3 3.0 31.0 - 40.7  39.0 1.7 36.6 - 42.1 1.67 0.110 
Gestational age at scan (weeks) 40.6 2.1 37.3 - 43.1  41.6 1.9 37.6 - 44.1 1.24 0.227 
          
Substance use          
Methamphetamine (days/month) 7.1 3.5 1.5 - 12.0  0.0 0.0 0.0 - 0.0 -7.04 0.000 
Smoking (number cigarettes/day) 6.5a 5.4 2.0 - 20.0  3.3
b 2.8 0.0 - 7.7 -1.78 0.089 
Marijuana (days/month) 4.4c 9.6 0.0 - 30.5  0.0
d 0.1 0.0 - 0.2 -1.58 0.129 
Alcohol (oz AA /day) 0.2e 0.4 0.0 - 1.4   0.0f 0.0 0.0 - 0.1 -1.26 0.222 
          
a11/11 (100%) and b8/12 (66.7%) smoked cigarettes; c5/11 (45.5%) and d2/12 (16.7%) used marijuana; e5/11 (45.5%) and f1/12 (8.3%) drank alcohol during pregnancy. 
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Table 4.2. Association of methamphetamine exposure with FA in the five networks (N=23).  
β values are non standardised. Xacq = value following regression with acquisition sequence. Xconf = value following 
regression with all significant confounding variables. Significant results are highlighted in boldface. Age = 
gestational age at scan (weeks); ses = Hollingshead socioeconomic status. 
 
4.3.3 Association of prenatal methamphetamine exposure with FA in white matter 
networks 
The association of methamphetamine exposure with FA in each of the five WM networks is 
shown in Table 4.2. Following an initial linear regression to control for acquisition sequence 
(DTI sequence used), FA was shown to be significantly associated with increasing 
methamphetamine exposure in the right projection fibre network and the left and right 
association fibre networks. Prenatal methamphetamine exposure was associated with FA at a 
trend-level (p < 0.1) in the commissural and left projection fibre networks. Confounding 
variables were included in the regression analysis of each network if they showed a weak 
association with FA in that network. Following the addition of confounding variables in the 
multivariate linear regression analysis, increasing methamphetamine exposure was observed 
to be significantly associated with FA reductions in all five WM networks. 
The individual WM-ROIs within each network showing associations (at p < 0.1) of 
methamphetamine exposure with FA are listed in Table 4.3. In the projection fibre networks, 
increased methamphetamine exposure was significantly associated with decreased FA bilater-
Network βacq pacq βconf pconf Confounders added 
 (E-03)  (E-03)   
      
Commissural -1.90 0.087 -1.49 0.034 age, alcohol, ses, sex 
      
Left projection -1.54 0.051 -1.79 0.001 age, ses, marijuana, sex 
      
Right projection -2.66 0.041 -2.86 0.009 age, ses, sex 
      
Left Association -1.75 0.032 -2.41 0.005 age, education, ses, marijuana, sex 
      
Right Association -2.11 0.017 -1.57 0.044 age, sex 
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Table 4.3. WM-ROIs showing associations of FA with methamphetamine exposure (N=23). 
Network WM-ROI Methamphetamine Control βacq pacq β pconf Confounders 
  FA (mean ± SD) FA (mean ± SD) (E-03)  (E-03)   
         
Left Projection 001-007 0.244 ± 0.015 0.254 ± 0.025 -1.92 0.082 -2.86 0.004 age, ses, marijuana, sex 
 004-006 0.253 ± 0.019 0.261 ± 0.022 -2.41 0.005 -2.77 0.010           
Right Projection 001-005 0.255 ± 0.014 0.277 ± 0.043 -3.01 0.099 -3.93 0.023 age, ses, sex 
 002-003 0.185 ± 0.023 0.201 ± 0.032 -2.74 0.073 -3.02 0.024  
 004-005 0.249 ± 0.011 0.268 ± 0.024 -2.27 0.036 -2.65 0.003  
 004-006 0.251 ± 0.015 0.264 ± 0.026 -2.76 0.005 -3.26 0.001  
 004-007 0.253 ± 0.012 0.273 ± 0.036 -2.81 0.063 -3.78 0.010  
 007-008 0.183 ± 0.019 0.194 ± 0.023 -2.76 0.011 -2.70 0.010           
Left Association 001-003 0.174 ± 0.021 0.187 ± 0.020 -2.28 0.040 -1.94 0.035 age, education, ses, marijuana, sex 
 003-007 0.235 ± 0.013 0.245 ± 0.027 -2.11 0.051 -2.59 0.031 
 005-007 0.188 ± 0.016 0.192 ± 0.021 -1.72 0.078 -3.17 0.004  
 006-007 0.215 ± 0.025 0.222 ± 0.019 -2.25 0.047 -2.55 0.074  
 007-009 0.232 ± 0.017 0.236 ± 0.017 -2.01 0.010 -2.44 0.005           
Right Association 001-002 0.197 ± 0.023 0.214 ± 0.026 -3.06 0.018 -2.33 0.045 age, sex 
 005-007 0.176 ± 0.010 0.182 ± 0.016 -1.33 0.044 -1.21 0.098  
 006-007 0.232 ± 0.025 0.238 ± 0.038 -3.07 0.028 -3.19 0.034  
 006-008 0.217 ± 0.020 0.228 ± 0.023 -2.88 0.006 -1.88 0.028  
         
β values are non-standardised. Xacq = following regression with acquisition sequence. Xconf = following regression with all significant confounding variables. Significant 
results are highlighted in boldface. Age = gestational age at scan (weeks); ses = Hollingshead socioeconomic status. 
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ally in 1 WM-ROI, 004-006. In the left projection fibre network, increased methamphetamine 
exposure was significantly associated with decreased FA in the WM-ROI 001-007, while the 
right showed significant negative association between methamphetamine exposure and FA in 
five additional WM-ROIs (001-005, 002-003, 004-005, 004-007 and 007-008). In the 
association fibre networks, 2 WM-ROIs showed a negative association between 
methamphetamine exposure and FA which was significant in one hemisphere and at a trend-
level in the other (005-007 and 006-007). Three additional WM-ROIs showed a significant 
association between increased methamphetamine exposure and reduced FA in the left 
hemisphere only (001-003, 003-007 and 007-009). In the right hemisphere, there was a 
significant association between methamphetamine exposure and FA in 2 additional 
connections (001-002 and 006-008). 
 
4.3.4 Association of prenatal methamphetamine exposure with AD and RD in white 
matter networks 
Networks which showed an association between methamphetamine exposure and FA were 
further analysed to investigate whether this association was driven by an association with 
methamphetamine of either AD or RD. Following multiple linear regression with acquisition 
sequence and significant confounding variables, AD was shown to be significantly associated 
with prenatal methamphetamine exposure in the commissural fibre network (β = 4.42 x10-3, p 
= 0.029). AD was associated with methamphetamine exposure in the right association network 
but this result did not survive after it was adjusted for confounding variables. RD was observed 
to be significantly associated with methamphetamine exposure in the right projection fibre 
network (β = 5.33 x10-3, p = 0.033).
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Table 4.4. Association of methamphetamine exposure with RD in individual WM-ROIs (N=23). 
Network WM-ROI Methamphetamine Control βacq pacq β pconf Confounders 
  RD (mean ± SD) RD (mean ± SD) (E-03)  (E-03)   
Right Projection 001-005 1.005 ± 0.048 0.964 ± 0.069 5.88 0.075 5.46 0.024 age, ses, sex 
 002-003 1.231 ± 0.088 1.178 ± 0.104 10.4 0.043 8.64 0.028  
 004-005 1.071 ± 0.051 1.038 ± 0.070 5.92 0.073 5.19 0.055           
Left Association 001-003 1.256 ± 0.095 1.194 ± 0.079 10.0 0.035 7.98 0.030 age, education, ses, marijuana, sex 
         
Right Association 001-002 1.202 ± 0.071 1.156 ± 0.075 8.08 0.033 6.99 0.017 age, sex 
 005-007 1.204 ± 0.055 1.173 ± 0.067 6.56 0.036 4.94 0.098  
         
β values are non-standardised. Xacq = following regression with acquisition sequence. Xconf = following regression with all significant confounding variables. Significant 
results are highlighted in boldface. Age = gestational age at scan (weeks); ses = Hollingshead socioeconomic status. 
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Individual WM-ROIs within each network which showed an association between 
methamphetamine exposure and FA were similarly analysed to investigate whether this 
association was driven by AD or RD. Following multiple linear regression with acquisition 
sequence and confounding variables, no WM-ROIs showed any association between 
methamphetamine exposure and AD. Several connections showed a positive association 
between methamphetamine exposure and RD, and the results of these analyses are shown in 
Table 4.4. In the right projection fibre network, 001-005 and 002-003 showed a significant 
association, while the association in 004-005 just escaped significance. In the left association 
fibre network, RD in 001-003 was significantly associated with methamphetamine exposure. 
In the right association fibre network, RD in 001-002 was significantly associated with 
methamphetamine exposure, while 005-007 was associated at a trend-level. 
 
4.4 DISCUSSION 
This forms part of the first study to investigate the microstructural effects of prenatal 
methamphetamine in neonates using DTI tractography. Alterations were observed in the three 
major classes of white matter tracts in the CNS: commissural fibres, projection fibres (both 
hemispheres) and association fibres (both hemispheres). Following regression for significant 
confounding variables, increasing methamphetamine exposure was shown to be associated 
with reduced FA in all five networks. Methamphetamine was significantly correlated with 
increased AD and RD in one network each. Connections between individual ROIs within the 
projection and association fibre networks were observed to show a significant negative 
correlation between methamphetamine and FA. These included fibres in the corticospinal 
tracts, the internal capsule, the optic radiation and superior and posterior thalamic radiations in 
the projection networks; and the uncinate, occipitofrontal and superior and inferior longitudinal 
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fasciculi in the association networks (see 193). At the individual connection level no effect of 
methamphetamine on AD was observed, but increased RD was associated with 
methamphetamine exposure in several WM-ROIs. 
These results are in agreement with previous studies which examined white matter 
characteristics in an older cohort from the same geographic region. Roos and colleagues 
observed reduced FA in a number of white matter tracts in 6-7 year-old children, including the 
external capsule, sagittal stratum and fornix, which connect striatal, frontal and limbic 
regions82. RD was increased in the corresponding regions. Reduced FA and increased AD and 
RD were observed at 1 month in the corona radiata of 1 month-old infants with combined 
methamphetamine and tobacco exposure compared to infants with tobacco exposure only or 
controls90. Most studies of adult methamphetamine users have used a voxel-based approach to 
analyse DT images, and many have found reduced FA in frontal regions28,31,187. Not all findings 
in prenatally exposed children are in full agreement, however. An investigation in a cohort of 
3-4 year-old children with methamphetamine exposure found reduced diffusivity and a trend 
for increased FA in frontal and parietal white matter91. Another group observed significantly 
increased FA in major white matter bundles including the CC, internal and external capsules 
and corona radiata, with increased AD and reduced RD92. The reasons for these inconsistencies 
are not fully apparent. One possible explanation may be methodological: the two studies which 
observed increased FA both used a voxel-wise method of analysis91,92, while the current 
research used a tractographic approach. However, a voxel-wise approach was also used by 
Roos and colleagues, who found reduced FA82.  
Interpretation of the DT measurements and the changes therein is complex. FA is often 
interpreted as a measure of the structural integrity of white matter, with increased FA being 
representative of more organisation135. Reduced FA has been observed in white matter tracts 
of patients with a range of psychiatric and neurodegenerative disorders194–197, but the exact 
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biochemical and structural nature of the pathology underlying the reductions is not directly 
apparent from this index alone123. FA alterations may be related to disruption in myelin 
structure or damage to the axons198 or to changes in fluid content in the examined region123. 
Evaluation of additional diffusion measures such as AD and RD can provide a more complete 
picture. Reductions in FA may be the result of lower AD or increased RD122, and these 
measures are differentially affected by the underlying pathology, with AD being sensitive to 
axonal degeneration and RD more severely affected by alterations in myelination199,200. 
Reduced FA was observed in the current study to be associated with methamphetamine 
exposure in all five major white matter networks examined. In all but one, increasing 
methamphetamine exposure was associated with increased RD, suggesting that the change in 
FA may be particularly the consequence of alterations in myelination, as the change in AD was 
less consistent or widespread. Prenatal methamphetamine exposure is associated with reduced 
myelination and myelin content in rats201,202, and methamphetamine has been shown to induce 
oligodendroglial cell death in vitro203. In concert with findings of reduced FA and increased 
RD in adult methamphetamine users30,31, these data suggest that methamphetamine exposure 
is associated with reduced white matter integrity particularly as a result of damage or alterations 
to myelin structure. The changes in AD, albeit to a lesser extent, should not be ignored, 
however. Previous studies of prenatal exposure in older children82,92 and of methamphetamine 
abuse in adults30,31 demonstrated AD alterations. There is some evidence that 
methamphetamine exposure induces axonal damage. Prenatal treatment with 
methamphetamine resulted in a higher percentage of smaller axons in rats202, while treatment 
with amphetamines induced significant terminal and axonal loss in the striatum of rats204 and 
baboons205 and reduction of axon density in the medial prefrontal cortex206. The precise 
mechanisms of methamphetamine damage to white matter are thus likely multifactorial.  
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Interpretation of diffusion measures in neonates is further complicated by the fact that the 
neonatal brain is far from fully developed. Axonal connections are organised into fibre bundles 
in the last trimester of gestation, but the myelination process is ongoing from the second half 
of pregnancy and is significantly incomplete at birth101. In addition, the maturation of white 
matter in the infant brain is considerably regionally variable, with a general progression of 
maturation in posterior-to-anterior and central-to-peripheral directions207. Diffusion indices 
change with white matter maturation such that FA increases while AD, RD and MD 
decrease124, which has been suggested to be the result of reduced brain water, increases in fibre 
diameter and myelination, more cohesive fibre tract arrangement and greater axonal packing208. 
Alterations in diffusion indices in the current study might therefore be considered to be an 
indication of delayed maturation in the white matter of exposed neonates. Lending credence to 
this interpretation are a number of preclinical studies which have found delays in somatic 
development209, locomotor control210 and sensory-motor development211, and slowed 
maturation of frontal cortical density212 in rats following amphetamine administration during 
gestation. Furthermore, the trajectories of FA and diffusivity measures were shown to be 
altered in corona radiata of infants with combined methamphetamine and tobacco exposure 
compared to controls90. 
White matter microstructure and connectivity are highly functionally significant. White matter 
pathways in the CNS are responsible for the transmission of information across networks and 
the integration and coordination of the activity of multiple individual regions213. A substantial 
body of literature supports the role of white matter in cognition. FA was shown to be associated 
with visuospatial information processing and sustained intelligence in school-age 
children208,214. The latter study additionally found that FA across multiple white matter regions 
was positively associated with IQ. The current study investigated changes in three major 
classes of white matter fibre tracts: callosal or commissural fibres connect cortical regions 
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across hemispheres; projection fibres connect cortical regions with spinal cord, brain stem, 
cerebellum and deep nuclei; and association fibres provide connections between cortical 
regions within the same hemisphere193. A number of studies have shown associations between 
specific fibre tracts and cognition in various domains. Higher white matter integrity, as 
measured by diffusion parameters, in the corona radiata, superior longitudinal fasciculus, 
posterior thalamic radiation and cerebral peduncle was associated with greater cognitive 
control, selective attention and interference suppression in school-age children215. Verbal 
ability was significantly associated with FA in the superior longitudinal fasciculus bilaterally 
and the left anterior thalamic radiation, and negatively with RD in the superior longitudinal 
fasciculi, the inferior longitudinal fasciculus and uncinate fasciculus in the left hemisphere and 
in forceps major216. Increased FA in fronto-parietal connections, particularly in the superior 
longitudinal fasciculus, was associated with better performance in a test of spatial working 
memory217. In infants, higher FA and reduced RD in anterior and superior thalamic radiations, 
anterior cingulum, arcuate fasciculus and temporo-parietal connections was related to better 
performance on a test of working memory218. Prenatal methamphetamine exposure in the 
current study was associated with poorer white matter integrity in a number of the above-
mentioned connections, and might therefore reasonably be assumed to be related to dysfunction 
in a number of domains. This assumption is borne out by previous literature which has shown 
alterations in white matter structure as a consequence of methamphetamine exposure to be 
associated with a number of functional deficits. In adult users, FA was associated with several 
clinical indices of depression and affective disorder187, with impairments in executive 
function28 and with poorer measures of cognitive control29. In children with prenatal exposure, 
altered FA in several white matter regions was significantly associated with poorer motor 
coordination and with cognitive control and executive function82. Further investigations into 
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the effects of prenatal exposure in cognitive domains relating to specific white matter tracts is 
highly warranted. 
To our knowledge, this is the first study to use DTI tractography to investigate white matter 
changes in neonates with prenatal exposure to methamphetamine. Studies in neonates of drug 
exposure effects have a significant advantage over studies in older cohorts. Children of women 
who abuse methamphetamine during pregnancy are almost invariably born into a suboptimal 
and disadvantageous environment81, which has been shown to exert further damaging 
influences on development79,170. Evaluation of prenatal methamphetamine exposure in 
neonates permits an assessment relatively free of the potential confounding influences 
associated with the post-natal environment.  
The women whose infants were scanned in the current study were recruited during pregnancy, 
allowing a more accurate measure of frequency of methamphetamine use. The timeline follow-
back approach to determining substance use130,131 provided a significant advantage in the 
current investigation over studies of older children in which precise measurement of drug use 
by the mother is almost impossible. A more informed quantitative analysis of 
methamphetamine exposure is thus feasible; of the limited previous studies of prenatal 
methamphetamine exposure, only one investigated potential associations between 
methamphetamine and diffusion properties91. As mentioned above, development of the CNS is 
far from complete at birth. This raises the possibility that effects observed during the neonatal 
period may be transient and resolve with maturation. Longitudinal investigations which follow 
cohorts from infancy as they mature will be invaluable in this regard. Given that our findings 
agree with previous results in both infants and older children, however, it is likely that the 
observed alterations will not resolve with age. 
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There are a number of limitations to this study. A significant limitation, almost inevitable in 
any study of prenatal drug exposure, is the potential confounding effects of polysubstance 
exposure93. The current study observed alcohol, cigarette and marijuana use by both control 
and methamphetamine-using mothers, with more in the methamphetamine group using each 
substance than in the control group, although a significant group difference was approached 
only for cigarette use. Prenatal exposure to all three has been demonstrated in animal and 
human studies to induce alterations in CNS structure and function135,152,155,219–223. However, as 
mentioned above, recruitment during pregnancy permits a far more accurate measure of 
substance use, so that alcohol, tobacco and marijuana use were included as confounding 
variables in the statistical analysis. A previous study of methamphetamine exposure which 
observed increased FA in frontal white matter, in contrast to the present findings, did not 
control for either cigarette or marijuana exposure92. Given that prenatal exposure to tobacco 
smoke has been shown to be associated with increased FA in frontal white matter223, this could 
explain the contradiction with the results of the current study. Chang and colleagues noted that 
methamphetamine-using women smoked more cigarettes than women who smoked but did not 
use methamphetamine90, suggesting that the effect of nicotine is likely to be higher in 
methamphetamine-exposed children. An additional limitation is the fairly small sample size. 
However, it is comparable to previous work82 and alterations were observed in regions which 
have been noted previously. It is possible that with a larger cohort some of the trend-level 
associations would have reached significance. As mentioned above, development of the CNS 
is far from complete at birth. This raises the possibility that effects observed during the neonatal 
period may be transient and resolve with maturation. Longitudinal investigations which follow 
cohorts from infancy as they mature will be invaluable in this regard. Given that our findings 
agree with previous results in both infants and older children, however, it is likely that the 
observed alterations will not resolve with age. 
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Literature on white matter alterations in prenatally methamphetamine exposed children is not 
unanimous, but the findings presented here agree with previously published results showing 
reduced anisotropy and increased radial diffusion in a significant number of major white matter 
connections. The current study extends previous findings to show that these alterations are 
associated with increased methamphetamine exposure in exposed infants, investigated by 
tractographic analysis in the first month postpartum. Given that the affected tracts have 
considerable functional significance, it is to be assumed that these changes will have a serious 
impact on the exposed children. Further research into the precise cognitive changes associated 
with such findings will be essential to inform the necessary therapeutic interventions. 
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CHAPTER 5 
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CORTICOSTRIATAL WHITE MATTER CHANGES ARE 
ASSOCIATED WITH PRENATAL METHAMPHETAMINE EXPOSURE 
5.1 INTRODUCTION 
The abuse of methamphetamine is one of the most rapidly growing drug problems worldwide13, 
with studies suggesting that it is second only to marijuana in global use117,224. It is a potent 
psychostimulant, exerting its effects primarily on the CNS by altering the release and activity 
of the monoaminergic neurotransmitters, dopamine, norepinephrine and serotonin181,225,226. 
Although the mechanisms of action of methamphetamine are not fully understood, a large body 
of preclinical and clinical literature has demonstrated its neurotoxic capabilities. Alterations in 
a number of brain areas, including the basal ganglia18,19,227, hippocampus23, amygdala25, 
thalamus228,229 and a range of cortical regions21,228,230,231, have been observed in both current 
and abstinent users, and several studies have shown an association between methamphetamine-
induced damage and altered cognitive or affective function23,46,51,183. 
The incidence of methamphetamine use by pregnant women has been estimated at over 5%54,67. 
Methamphetamine causes vasoconstriction and reduced placental blood flow57, resulting in 
damage to the placenta58 and hypoxia in the fetus67. A range of adverse perinatal effects on 
both mother and infant have been associated with methamphetamine use in pregnancy, 
including higher incidence of gestational hypertension and preeclampsia and increased risk of 
fetal and neonatal death142. Gestational age at birth has been observed to be lower in exposed 
infants59,65, with an increased risk of preterm birth141. Methamphetamine exposure has also 
been shown to be associated with smaller size at birth63–65,75,141 and lower birth weight64,141. 
In the light of the above-mentioned effects and the well-documented neurotoxicity of 
methamphetamine in adult abusers, it is logical to conclude that exposure during the 
neurologically vulnerable prenatal period would induce potentially severe and long-term 
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alterations. CNS growth and development is rapid and complex during gestation72,101, and the 
influence of a highly neuroactive drug such as methamphetamine might well be expected to 
induce significant modifications. 
DTI is a neuroimaging modality that enables visualisation and characterisation of white matter 
within the CNS by analysing the three-dimensional diffusion of water molecules within fibre 
bundles125,192. From the extracted data various measures of the structural integrity of the white 
matter bundles and their component axons can be determined. AD is a measure of the diffusion 
of water molecules in the direction parallel to the white matter fibres, while RD measures 
perpendicular movement. The most widely used measure of water movement is FA, which 
represents the normalised standard deviation of the total diffusivities123. Higher FA is a 
reflection of diffusion that is primarily in a direction parallel to the longitudinal axis of the 
white matter fibre bundles125, and is generally regarded as a marker of more healthy, highly 
structured or mature white matter122. 
Information from DT images relating to the directionality and alignment of water diffusion can 
be used to map the trajectories of white matter fibre bundles within the brain120,123 by 
determining fibre orientation from the principal diffusion vector in sequential voxels101. By 
defining regions of interest, the path of fibres within connecting tracts can then be defined232 
and the microstructure of the fibre bundles determined by analysing the diffusion measures 
across the entire tract125. Changes in diffusion measures within a fibre bundle are frequently an 
indication of functional alterations186, with many pathologies affecting the microstructure and 
organisation of CNS white matter122, and DTI is a valuable tool for investigating and 
quantifying the extent and nature of these changes. 
An appreciable body of evidence shows significant effects of methamphetamine use on 
diffusion measures. Recently abstinent methamphetamine users exhibit reduced FA in frontal 
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cortical regions28,31,187 and in the genu of the CC29,30,187. Higher AD and RD have been noted 
in the caudate and putamen of methamphetamine users31, although no such striatal effects were 
observed by Lin and colleagues188. 
In the light of these findings, it is reasonable to hypothesise that prenatal methamphetamine 
exposure would exert similar deleterious effects on CNS structure in the exposed fetus. There 
is a sparsity of DT imaging literature examining such effects, however, and the results are not 
unanimous. Lower FA and increased MD, AD and RD were observed in white matter tracts 
passing through striatal, limbic and frontal cortical regions of 6-7 year old children with 
prenatal methamphetamine exposure82. Similarly, lower FA and increased AD and RD in the 
corona radiata were observed in infants exposed to methamphetamine and tobacco90. In a study 
of 9-11 year old children, however, exposure was associated with higher FA in the genu of the 
CC, corona radiata and internal and external capsules92, while similar results were observed in 
a voxel-based study of a 3-4 year old cohort, which noted increased FA and reduced diffusivity 
in genu and splenium of the CC, frontal and parietal white matter and the basal ganglia91. 
There is thus agreement in the literature that in utero exposure to methamphetamine induces 
significant and enduring effects on CNS white matter, but the precise nature of these changes 
bears further investigation. Moreover, to date there are no published studies of DT tractography 
of methamphetamine exposure in neonates. Children born to women who abuse 
methamphetamine are almost invariably exposed to a suboptimal environment65,81, and this is 
likely to have strong effects on neural development. Investigations of neonatal cohorts permit 
a cleaner separation of substance exposure effects from the potential confounding influences 
of the postnatal environment. 
A previous ‘whole-brain’ analysis of the current cohort revealed altered diffusivity and reduced 
FA in three major classes of white matter tracts, commissural, projection and association fibres, 
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indicating a generalised effect of methamphetamine exposure on white matter microstructure 
(unpublished work). The aim of the current study was to investigate potential changes in white 
matter fibre bundles forming part of the corticostriatal and mesolimbic connections between 
OFC and subcortical ROIs which were previously manually defined in this cohort. It was 
hypothesised that prenatal methamphetamine exposure would be associated with 
microstructural alterations in these regions. 
 
5.2 METHODS 
5.2.1 Study sample 
The study sample consisted of infants born to women from the Cape Coloured (mixed ancestry) 
community from Cape Town, South Africa, who form part of a larger prospective longitudinal 
study of prenatal alcohol and drug exposure on infant development58,132,135. The exposed group 
comprised infants with prenatal exposure to methamphetamine, while the control group 
comprised infants from the same community without methamphetamine exposure and with 
minimal or no exposure to alcohol or other drugs of abuse in utero. 
Pregnant mothers were recruited following antenatal care bookings at midwife obstetric care 
units in the community. They were interviewed three times during pregnancy with regard to 
their methamphetamine and alcohol consumption by means of a time-line follow-back 
approach130,131, as well as about cigarette and other drug use during pregnancy. The current 
study group consisted of women in the cohort who reported the use of methamphetamine on at 
least 2 occasions per month during pregnancy. The control group included women who 
abstained from alcohol and other drugs of abuse, or who consumed no more than 2 drinks on 
no more than 2 occasions during their pregnancy. 
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Informed consent was obtained from each mother at recruitment and at the first laboratory visit. 
Ethics approval for the study was obtained from the ethics committees at Wayne State 
University and the Faculty of Health Sciences of the University of Cape Town. 
 
5.2.2 Scanning 
Infants were scanned without use of sedation, between 1 and 5 weeks postpartum, with the 
exception of one infant, born at 31 weeks gestational age, who was scanned at 9 weeks of age. 
Scanning took place at the Cape Universities Brain Imaging Centre (CUBIC) at the Faculty of 
Health Sciences campus of the University of Stellenbosch, South Africa. 
The infants were brought to the centre a minimum of 1 hour prior to scanning. During the pre-
scan period the infants were weighed, head circumference and crown-to-heel length were 
measured, and neonatal behavioural characteristics145 were assessed. The infant was then 
firmly swaddled and placed in a VacFix® vacuum cushion (S&S Par Scientific, Houston, TX). 
Earplugs were used to protect the infant from scanner noise. The infant was fed by the mother 
and allowed to fall asleep.  
The infant was placed in the scanner and immobilised using the VacFix® cushion, following 
an adapted protocol for neuroimaging of nonsedated neonates146. A pulse and oxygen saturation 
monitor probe was secured to the infant’s foot, and this was monitored during the scanning 
process by a developmental paediatrician, or by a research nurse, who remained in the scanner 
room with the infant throughout the procedure. 
MRI scanning was performed using a Siemens 3T Allegra scanner. A circularly polarised bird-
cage coil, custom-built for use with neonates, was used for transmission and reception of the 
signal. Two DWI sets with opposite (AP/PA) phase encoding directions were acquired with a 
twice refocused spin echo EPI sequence. For 5 infants (1 with methamphetamine exposure, 4 
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controls), the scanning parameters were as follows: TR 9500 ms, TE 86 ms, matrix 50 slices 
of 80x80 voxels, voxel size 2x2x2 mm3. The remaining infants were scanned using a similar 
DTI sequence which included navigation for performing real-time motion detection and 
correction189; this had the same scanning parameters as above, but with TR = 10 026 ms. In 
both navigated and non-navigated sequences, AP and PA acquisitions each contained four b = 
0 s.mm-2 reference scans and 30 DW gradient directions with b = 1000 s.mm-2.  
For anatomical imaging, a motion-navigated multiecho gradient echo sequence190 was used, 
with protocol parameters as follows: FOV 114 mm, 128 slices of 144x144 voxels, voxel size 
1x1x1 mm3,  TR 20 ms, TE 1.46/ 3.14/ 4.82/ 6.5/ 8.18/ 9.86/ 11.54/ 13.22 ms. Two sets were 
acquired, with flip angles of 5° and 20° respectively.  
 
5.2.3 Data processing and parameter estimation 
DWI data were inspected visually for motion artifacts and dropout slices, and individual poor 
quality volumes were discarded. At least 12 DWIs remained for each infant. Motion and EPI 
distortion were corrected using FSL’s eddy correct and topup tools137. DTs and tensor 
parameters such as FA, MD, eigenvalues (Li, i=1,2,3; AD=L1; RD=[L2+L3]/2) and directional 
eigenvectors (ei, i=1,2,3) were estimated using AFNI
191. 
For the anatomical images, individual echoes from the two flip angle acquisitions were 
combined using mri_ms_fitparms using FreeSurfer147,233. From this, tissue parameters were 
estimated and a single image volume, with an optimal contrast flip angle of 24°, was 
synthesised. 
 
5.2.4 Manual tracing of target regions of interest 
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Regions of interest were viewed and manually delineated using Freeview software (the 
FreeSurfer image analysis suite http://surfer.nmr.mgh.harvard.edu/) run on a Lenovo ThinkPad 
X220 tablet (see Fig. 5.1). A subset of these traced ROIs were used as targets for tractographic 
analysis. The following previously traced ROIs were used bilaterally: caudate, nucleus 
accumbens, putamen, hippocampus and amygdala. Two additional regions were traced for the 
purposes of this study – the midbrain and the OFC.  
5.2.4i Caudate nucleus and nucleus accumbens (NAcc) 
An oblique line from the inferior tip of the lateral ventricle to the midpoint of the inferior 
boundary of the internal capsule was drawn to separate the caudate and nucleus accumbens, 
while a line descending from the middle of the inferior border of the anterior limb of the internal 
capsule was taken to define the boundary between the putamen and the nucleus accumbens.  
Posteriorly, the caudate diminishes in size and eventually becomes difficult to define as the tail 
reaches the point where it curves inferiorly posterior to the thalamus. For this reason the 
posterior and inferior portions of the caudate were not traced.  
5.2.4ii Putamen 
The junction of putamen and pallidum was generally most clearly seen in axial sections, so that 
tracing was done in the axial or coronal planes on a slice by slice basis. 
5.2.4iii Hippocampus 
The hippocampus was traced chiefly in the coronal plane, with considerable guidance from 
views in the sagittal plane. It can be seen in sagittal sections within the temporal lobe as a 
sausage-shaped structure. More anteriorly in the coronal plane the hippocampal head appears, 
and the structure becomes large and rounded. 
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Figure 5.1. Traced ROIs used as seeds for probabilistic tractography, shown in sagittal view in upper 
panels, and coronal and axial views in left and right lower panels respectively. 1) orbitofrontal cortex; 
2) hippocampus; 3) amygdala; 4) caudate nucleus; 5) putamen; 6) nucleus accumbens; 7) midbrain. 
Regions are numbered in one hemisphere only but were traced bilaterally. 
 
5.2.4iv Amygdala 
The amygdala is located anterior to the head of the hippocampus. It is bounded in its anterior, 
inferior and lateral aspects by white matter, and postero-inferiorly by the hippocampus and the 
tip of the lateral ventricle. The tracings of the amygdala were done in all three planes, as it was 
difficult to see in its entirety in any one plane.  
5.2.4v Midbrain 
The region described as midbrain included the complete midbrain (as defined anatomically), 
encompassing tectum, tegmentum, and crus cerebri. The lower border corresponded with the 
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mesencephalic/ pontine boundary at the upper border of the basilar pons. Superiorly, care was 
taken to exclude the subthalamic area which is easily identifiable in neonatal brains. 
5.2.4vi Orbitofrontal cortex 
The OFC was defined as that area of cortex situated on the inferior surface of the frontal lobe. 
Its anterior and lateral borders were defined by the hemispheric edge where the lateral and 
inferior frontal surfaces meet. Its posterior boundary was defined by the posterior edge of 
cortex on the inferior surface. The OFC was traced in one control subject, following which 
nonlinear registration was performed between the b0 reference volume of this subject and each 
of the others in the study using AFNI's 3dQwarp.  The calculated transformation was then 
applied to map the ROIs into each subject's native diffusion space.  
 
5.2.5 Tractographic analysis 
Probabilistic tractography was performed using the FATCAT software in AFNI127. Local 
uncertainties in DT eigenvectors and FA were estimated with FATCAT, and probabilistic 
tractography was performed using the FACTID algorithm, which uses repeated iterations of 
whole brain tracking to estimate the most likely locations of white matter connections between 
pairs of targets139. The tract propagation parameters used were: maximum “turning” angle of 
propagation of 55 degrees, through voxels with FA > 0.1, which is the standard threshold for 
FA as a proxy for white matter in infants129. All voxels through which more than a minimum 
number of tracts passed to connect a pair of targets were included to create WM-ROIs 
associated with each pair of targets. Only WM-ROIs found between the same pairs of targets 
in all subjects were included for further analysis. The mean and standard deviation of the DTI 
parameters FA, AD and RD for each WM-ROI were automatically calculated by the tracking 
function. 
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5.2.6 Statistical analysis 
Statistics were performed using IBM SPSS Statistics (version 23; IBM, Armonk, NY). Ten 
variables were examined as potential confounders: maternal alcohol use (in units of absolute 
alcohol consumed per day across pregnancy), maternal marijuana use (days per month during 
pregnancy), maternal cigarette smoking during pregnancy (number of cigarettes per day during 
pregnancy), maternal education (highest grade level completed), maternal marital status, parity, 
socioeconomic status (ses; see Ref. 174), infant sex, gestational age at scan (measured in weeks), 
and birth weight (grams).  Data were examined for skewness and outliers were “winsorised”, 
that is, recoded to one unit greater than the next highest value148; this was applied to the 
methamphetamine, alcohol, marijuana and cigarette smoking exposure variables. Sample 
characteristics were compared between exposed and control groups using t-tests for continuous 
variables, or chi-squared tests for categorical variables. 
ANCOVA was used to compare the mean FA of each WM-ROI between exposed and control 
groups, adjusting for acquisition sequence (navigated or non-navigated). Variables weakly (p 
< 0.1) associated with FA for each WM-ROI were added in subsequent ANCOVAs. For WM-
ROIs in which group differences in FA had been observed, group differences 
(methamphetamine vs. control) in mean values of AD and RD were examined using the same 
procedure.  
Linear regression analyses were used to investigate potential associations between 
methamphetamine exposure (number of days/ month of pregnancy that methamphetamine was 
used) and mean FA in each WM-ROI, adjusting for acquisition sequence. WM-ROIs in which 
FA showed a trend towards significant association with methamphetamine were then analysed 
by means of hierarchical multiple linear regression with best estimate approach. Confounding 
variables showing some relationship to FA (p < 0.1) were entered successively according to 
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their strength of association with FA in the tract of interest. Variables which altered β by less 
than 10% were excluded from further modeling. WM-ROIs in which a significant association 
between FA and methamphetamine exposure was observed were further analysed in terms of 
AD and RD. 
 
5.3 RESULTS 
5.3.1 Sample characteristics 
The final study sample for analysis comprised 23 infants, 11 with methamphetamine exposure 
and 12 controls. The demographic characteristics of the sample are summarised in Table 5.1.  
Of the maternal characteristics, only maternal education, measured as the highest grade level 
completed by the mother, was significantly different between groups (p < 0.05), with the 
methamphetamine group achieving a lower level of education than controls.  
The sample consisted of 12 male and 11 female infants, with 5 males and 7 males in the 
methamphetamine exposed and control groups, respectively. The number of male and female 
infants in each group was not statistically different between groups. Although infants with 
prenatal methamphetamine exposure tended to be born younger, there was no difference 
between the groups in gestational age at scan (gestational age at birth + age in weeks at scan) 
or in birth weight. 
In comparing substance use between groups, mean cigarette use by the mothers of the exposed 
group tended to be higher than that of the control group. Control mothers did not use 
methamphetamine, but 67% smoked, 17% used marijuana and 1 mother drank alcohol, 
although the latter was within the acceptable limits set for inclusion in the cohort. By contrast, 
100% of the mothers in the exposed group smoked, 46% (n = 5) used marijuana and 46% drank 
alcohol during pregnancy.
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Table 5.1. Sample characteristics (N=23). 
  
  
Methamphetamine (PEM) 
  
  
Control (Ctl) 
  
    
  (n= 11)    (n = 12)     
  Mean SD Range   Mean SD Range χ2 or t p 
Maternal                   
Age (years) 27.2 3.9 21.4 - 32.6  25.1 5.4 18.8 - 36.4 -1.05 0.305 
Education 9.4 1.2 7.0 - 11.0  10.6 1.1 9.0 - 12.0 2.56 0.018 
Parity 2.1 1.6 0 - 5  1.3 1.2 0 - 3 -1.44 0.165 
          
Infant          
Sex (% male) 45.5    58.3   0.38 0.537 
Birth weight (g) 2806.8 600.5 1370.0 - 3590.0  2795.8 485.2 1940.0 - 3470.0 -0.05 0.962 
Gestational age at birth (weeks) 37.3 3.0 31.0 - 40.7  39.0 1.7 36.6 - 42.1 1.67 0.110 
Gestational age at scan (weeks) 40.6 2.1 37.3 - 43.1  41.6 1.9 37.6 - 44.1 1.24 0.227 
          
Substance usea          
Methamphetamine (days/month) 7.1 3.5 1.5 - 12.0  0.0 0.0 0.0 - 0.0 -7.04 0.000 
Smoking (number cigarettes/day) 6.5b 5.4 2.0 - 20.0  3.3
c 2.8 0.0 - 7.7 -1.78 0.089 
Marijuana (days/month) 4.4d 9.6 0.0 - 30.5  0.0
e 0.1 0.0 - 0.2 -1.58 0.129 
Alcohol (oz AA /day) 0.2f 0.4 0.0 - 1.4   0.0g 0.0 0.0 - 0.1 -1.26 0.222 
          
amean, SD, range based on whole group (PEM, n=11; Ctl, n=12);  b11/11 (100%) and c8/12 (66.7%) smoked cigarettes; d5/11 (45.5%) and e2/12 (16.7%) used marijuana; f5/11 
(45.5%) and g1/12 (8.3%) drank alcohol during pregnancy. 
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Figure 5.2. Volumetric depiction of WM-ROIs produced by probabilistic tractography between 
manually traced seed ROIs in one control infant brain.  
 
5.3.2 Tractographic connections 
Probabilistic tractography produced 31 WM-ROI connections between target ROIs that were 
common to all infants. These are shown in Table 5.2. (See also Fig. 5.2). 
 
5.3.3 Comparison of mean WM-ROI parameters between methamphetamine and control 
groups 
The results of the comparison of mean FA in WM-ROIs of methamphetamine exposed and 
control infants are shown in Table 5.3 (only regions showing at least trend-level significance, 
p < 0.1, in any of the tests are shown). Representative examples of tractographic connections 
between traced ROIs in control and methamphetamine-exposed infants are shown in Fig. 5.3. 
With the inclusion of acquisition sequence as a standard confounding variable, mean FA was 
observed to be significantly lower in the methamphetamine group in 4 WM-ROIs: midbrain – 
left putamen, left putamen – left OFC, right putamen – right OFC, and right putamen – right 
amygdala. Three more WM-ROIs showed a trend towards reduced mean FA in the 
methamphetamine group compared to controls (midbrain – right caudate; midbrain – right 
putamen; right putamen – right hippocampus). 
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Table 5.2. List of WM-ROIs which are present in all subjects (N=23) and their group means. 
 Methamphetamine (n=11)  Control (n=12) 
 FA AD RD  FA AD RD 
  (x10-3 s/mm2) (x10-3 s/mm2)   (x10-3 s/mm2) (x10-3 s/mm2) 
WM-ROI mean SD mean SD mean SD  mean SD mean SD mean SD 
Midbrain - Left Hippocampus 0.223 0.031 1.699 0.068 1.211 0.068  0.220 0.036 1.683 0.124 1.208 0.118 
Midbrain - Right Hippocampus 0.227 0.027 1.682 0.084 1.190 0.077  0.232 0.028 1.705 0.079 1.195 0.066 
Midbrain - Left Caudate 0.235 0.014 1.486 0.075 1.029 0.043  0.240 0.018 1.440 0.060 0.988 0.056 
Midbrain - Right Caudate 0.230 0.014 1.469 0.069 1.028 0.039  0.248 0.044 1.455 0.061 0.986 0.068 
Midbrain - Left Putamen 0.243 0.018 1.466 0.044 1.002 0.045  0.258 0.025 1.472 0.076 0.982 0.067 
Midbrain - Right Putamen 0.245 0.012 1.467 0.050 1.002 0.035  0.252 0.020 1.440 0.034 0.970 0.046 
Left OFC - Left NAcc 0.160 0.020 1.618 0.122 1.275 0.100  0.165 0.016 1.555 0.120 1.217 0.098 
Right OFC - Right NAcc 0.161 0.019 1.622 0.107 1.273 0.090  0.167 0.028 1.583 0.099 1.232 0.104 
Left OFC - Left Amygdala 0.176 0.024 1.813 0.196 1.396 0.177  0.184 0.028 1.773 0.135 1.346 0.128 
Right OFC - Right Amygdala 0.178 0.029 1.780 0.159 1.366 0.161  0.179 0.032 1.827 0.180 1.398 0.165 
Left OFC - Left Caudate 0.191 0.013 1.689 0.084 1.263 0.074  0.192 0.017 1.640 0.090 1.231 0.091 
Right OFC - Right Caudate 0.189 0.017 1.703 0.067 1.278 0.073  0.199 0.031 1.683 0.096 1.243 0.108 
Left OFC - Left Putamen 0.181 0.013 1.605 0.054 1.229 0.050  0.191 0.013 1.588 0.070 1.196 0.061 
Right OFC - Right Putamen 0.176 0.011 1.632 0.078 1.258 0.071  0.190 0.019 1.593 0.081 1.199 0.077 
Left OFC - Left Hippocampus 0.232 0.021 1.762 0.113 1.238 0.070  0.239 0.020 1.801 0.151 1.252 0.120 
Left OFC - Right OFC 0.197 0.015 1.755 0.105 1.298 0.093  0.203 0.022 1.694 0.127 1.240 0.094 
Right OFC - Left Caudate 0.221 0.022 1.771 0.083 1.256 0.082  0.249 0.084 1.749 0.131 1.179 0.138 
Left Caudate - Left NAcc 0.176 0.018 1.722 0.134 1.319 0.094  0.175 0.022 1.642 0.111 1.261 0.096 
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Right Caudate - Right NAcc 0.182 0.018 1.734 0.116 1.316 0.074  0.184 0.027 1.692 0.132 1.283 0.105 
Left Caudate - Left Putamen 0.199 0.015 1.542 0.046 1.136 0.041  0.202 0.014 1.496 0.064 1.098 0.062 
Right Caudate - Right Putamen 0.201 0.015 1.545 0.056 1.135 0.044  0.203 0.016 1.520 0.072 1.113 0.064 
Left Caudate - Right Caudate 0.284 0.019 1.875 0.115 1.201 0.092  0.290 0.025 1.816 0.108 1.150 0.082 
Left Caudate - Left Hippocampus 0.241 0.017 1.678 0.122 1.159 0.091  0.253 0.022 1.709 0.144 1.156 0.114 
Left Putamen - Left NAcc 0.169 0.013 1.454 0.069 1.127 0.059  0.175 0.019 1.404 0.057 1.076 0.046 
Right Putamen - Right NAcc 0.168 0.022 1.458 0.068 1.131 0.049  0.175 0.021 1.442 0.064 1.108 0.059 
Left Hippocampus - Left Amygdala 0.198 0.023 1.564 0.070 1.151 0.054  0.197 0.025 1.567 0.074 1.156 0.083 
Right Hippocampus - Right Amygdala 0.186 0.016 1.558 0.054 1.171 0.046  0.193 0.022 1.599 0.077 1.188 0.075 
Left Putamen - Left Hippocampus 0.253 0.012 1.612 0.062 1.089 0.046  0.256 0.024 1.643 0.109 1.106 0.085 
Right Putamen - Right Hippocampus 0.255 0.015 1.607 0.049 1.084 0.032  0.270 0.024 1.640 0.072 1.078 0.078 
Left Putamen - Left Amygdala 0.220 0.030 1.478 0.063 1.052 0.081  0.242 0.027 1.499 0.053 1.029 0.078 
Right Putamen - Right Amygdala 0.220 0.031 1.507 0.046 1.074 0.068  0.253 0.020 1.518 0.054 1.023 0.057 
              NAcc = nucleus accumbens; OFC = orbitofrontal cortex 
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Table 5.3. Group differences in FA in WM-ROIs (N=23). 
 Methamphetamine (n=11) 
Control 
(n=12) 
    
WM-ROI (target1 – target2) Mean SD Mean SD Facq pacq Fconf pconf Confounders used 
Midbrain - Right Caudate 0.230 0.014 0.248 0.044 3.33 0.083 3.33 0.083 none 
           
Midbrain - Right Putamen 0.245 0.012 0.252 0.020 3.49 0.077 3.49 0.077 none 
           
Midbrain - Left Putamen 0.243 0.018 0.258 0.025 4.39 0.049 1.97 0.176 marijuana 
           
Left Putamen - Left OFC 0.181 0.013 0.191 0.013 5.65 0.028 4.15 0.056 age 
           
Right Putamen - Right OFC 0.176 0.011 0.190 0.019 6.02 0.023 4.38 0.050 age 
           
Right Putamen - Right Amygdala 0.220 0.031 0.253 0.020 7.48 0.013 6.73 0.019 birthweight, alcohol, sex 
           
Right Putamen - Right Hippocampus 0.255 0.015 0.270 0.024 3.95 0.061 2.72 0.116 age 
          
NAcc = nucleus accumbens; OFC = orbitofrontal cortex Xacq = value when controlling for acquisition sequence in the analysis; Xconf = value following addition of acquisition 
sequence and significant confounding variables into analysis; significant effects (p<0.05) are highlighted in boldface. Age = gestational age at scan (weeks). 
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Figure 5.3. Examples of mini-probabilistic tractography connecting manually traced seed ROIs in one 
control (A) and one methamphetamine-exposed (B) infant brain. Colouration is by local tract direction, 
with left-right depicted in red, anterior-posterior in green, and inferior-superior in blue. 
 
After controlling for additional confounding variables (listed in Table 5.3), the FA reductions 
in the right putamen – right OFC and right putamen – right amygdala survived. In 3 WM-ROIs 
a trend was observed towards reduced FA in the methamphetamine group compared to the 
controls (midbrain – right caudate; midbrain – right putamen; left putamen – left OFC). In 2 
WM-ROIs (midbrain – left putamen; right putamen – right hippocampus) the group effect was 
lost once the confounding variables were included. 
Tables 5.4 and 5.5 show the results of the comparison of mean AD and mean RD in WM-ROIs 
which showed significant or trend-level differences in mean FA between groups. No difference 
was observed in mean AD between methamphetamine exposed and control groups at any stage 
of the analysis in any WM-ROI. Increased RD in the methamphetamine group was observed 
in 2 WM-ROIs (midbrain – right caudate and right putamen – right OFC), and trend-level 
increases in another 2 WM-ROIs (midbrain – right putamen and right putamen – right 
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Table 5.4. Group differences in AD in WM-ROIs (N=23). 
 
Methamphetamine 
(n=11) 
Control 
(n=12)      
WM-ROI (target1 – target2) Mean SD Mean SD Facq pacq Fconf pconf Confounders used 
Midbrain - Right Caudate 1.469 0.069 1.455 0.061 0.218 0.646 0.218 0.646 none 
          
Midbrain - Right Putamen 1.467 0.050 1.440 0.034 1.417 0.248 1.417 0.248 none 
          
Midbrain - Left Putamen 1.466 0.044 1.472 0.076 0.178 0.677 0.215 0.648 marijuana 
          
Left Putamen - Left OFC 1.605 0.054 1.588 0.070 0.558 0.464 0.059 0.811 age 
          
Right Putamen - Right OFC 1.632 0.078 1.593 0.081 1.681 0.210 0.733 0.403 age 
          
Right Caudate - Right Putamen 1.545 0.056 1.520 0.072 1.961 0.177 0.788 0.387 alcohol, age 
          
Right Putamen - Right Amygdala 1.507 0.046 1.518 0.054 0.147 0.706 1.259 0.277 birthweight, alcohol, sex 
          
Right Putamen - Right Hippocampus 1.607 0.049 1.640 0.072 0.959 0.339 1.258 0.276 age 
          
NAcc = nucleus accumbens; OFC = orbitofrontal cortex; Xacq = value when controlling for acquisition sequence in the analysis; Xconf = value following addition of acquisition 
sequence and significant confounding variables into analysis. Age = gestational age at scan (weeks). 
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Table 5.5. Group differences in RD in WM-ROIs (N=23). 
 
Methamphetamine 
(n=11) 
Control 
(n=12)      
WM-ROI (target1 – target2) Mean SD Mean SD Facq pacq Fconf pconf Confounders used 
Midbrain - Right Caudate 1.028 0.039 0.986 0.068 5.261 0.033 5.261 0.033 none 
           
Midbrain - Right Putamen 1.002 0.035 0.970 0.046 3.735 0.068 3.735 0.068 none 
           
Left Putamen - Left OFC 1.229 0.050 1.196 0.061 2.737 0.114 1.434 0.246 age 
           
Right Putamen - Right OFC 1.258 0.071 1.199 0.077 4.456 0.048 2.988 0.100 age 
           
Right Caudate - Right Putamen  1.135 0.044 1.113 0.064 2.776 0.111 2.352 0.142 alcohol, age 
           
Right Putamen - Right Amygdala 1.074 0.068 1.023 0.057 3.225 0.088 1.414 0.251 birthweight, alcohol, sex 
           
Right Putamen - Right Hippocampus 1.084 0.032 1.078 0.078 0.276 0.605 0.040 0.844 age 
          
NAcc = nucleus accumbens; OFC = orbitofrontal cortex; Xacq = value when controlling for acquisition sequence in the analysis; Xconf = value following addition of acquisition 
sequence and significant confounding variables into analysis. Significant results (p<0.05) are highlighted in boldface. Age = gestational age at scan (weeks). 
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amygdala). Following the addition of confounding variables, increased RD in the 
methamphetamine group only survived in the midbrain – right caudate connection, while RD 
in the methamphetamine group tended to be greater in the midbrain – right putamen.  
 
5.3.4 Regression of tract parameters and methamphetamine exposure 
The results of the regression analyses of FA and methamphetamine exposure are shown in 
Table 5.6. Linear regression including acquisition sequence as a standard confounding variable 
in all WM-ROIs showed that increasing methamphetamine exposure was significantly 
associated with reduced FA in 8 connections: midbrain – right caudate; midbrain – right 
putamen; left NAcc – left OFC; left putamen – left OFC; right NAcc – right OFC; right 
putamen – right OFC; midbrain – right hippocampus; and right putamen – right amygdala. A 
trend towards a significant association was observed in a further 7 connections (midbrain – left 
caudate; midbrain – left putamen; right caudate – right OFC; right putamen – right 
hippocampus; left caudate – right caudate; left caudate – left hippocampus; left hippocampus 
– left OFC).  
Potential cofounding variables were included in subsequent regression analyses if they showed 
a correlation with FA in the relevant WM-ROI at p < 0.1. After control for confounders, 
associations of increased methamphetamine exposure with FA reductions in 7 of the eight WM-
ROIs survived. The association in the right putamen – right OFC connection became a trend, 
while the associations in 2 WM-ROIs, namely right caudate – right OFC and left caudate – left 
hippocampus, which showed trend-like associations initially, became significant. Weak 
associations were no longer evident in most of the other regions that showed a trend towards 
association previously, other than in the left hippocampus – left OFC connection. 
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Table 5.6. Regression of FA in WM-ROIs with methamphetamine exposure (N=23). 
 
Methamphetamine 
(n=11) 
Control  
(n=12)      
WM-ROI (target1 – target2) Mean SD Mean SD βacq pacq βconf pconf Confounders included 
Midbrain - Right Caudate 0.230 0.014 0.248 0.044 -0.45 0.038 -0.45 0.038 none 
          
Midbrain - Right Putamen 0.245 0.012 0.252 0.020 -0.41 0.048 -0.41 0.048 none 
          
Midbrain - Left Caudate 0.235 0.014 0.240 0.018 -0.38 0.089 -0.23 0.274 age 
          
Midbrain - Left Putamen 0.243 0.018 0.258 0.025 -0.42 0.061 -0.31 0.181 marijuana 
          
Left NAcc - Left OFC 0.160 0.020 0.165 0.016 -0.51 0.009 -0.44 0.020 marital status 
          
Left Putamen - Left OFC 0.181 0.013 0.191 0.013 -0.57 0.007 -0.42 0.027 age 
          
Right NAcc - Right OFC 0.161 0.019 0.167 0.028 -0.50 0.010 -0.50 0.010 none 
          
Right Caudate - Right OFC 0.189 0.017 0.199 0.031 -0.41 0.061 -0.37 0.043 age, birthweight, ses 
          
Right Putamen - Right OFC 0.176 0.011 0.190 0.019 -0.49 0.029 -0.364 0.094 age 
          
Midbrain - Right Hippocampus 0.227 0.027 0.232 0.028 -0.49 0.018 -0.49 0.018 none 
          
Right Putamen - Right Amygdala 0.220 0.031 0.253 0.020 -0.47 0.035 -0.47 0.035 none 
          
Right Putamen - Right Hippocampus 0.255 0.015 0.270 0.024 -0.43 0.060 -0.34 0.150 age 
          
Left Caudate - Right Caudate 0.284 0.019 0.290 0.025 -0.41 0.060 -0.16 0.352 age, sex 
          
Left Caudate - Left Hippocampus 0.241 0.017 0.239 0.020 -0.44 0.054 -0.44 0.049 age, ses 
          
Left Hippocampus - Left OFC 0.232 0.021 0.239 0.020 -0.43 0.054 -0.43 0.054 none 
          
NAcc = nucleus accumbens; OFC = orbitofrontal cortex; Xacq = value controlling for acquisition sequence in the analysis; Xconf = value following addition of acquisition 
sequence and significant confounding variables into analysis. Significant effects (p<0.05) are highlighted in boldface. Age = gestational age at scan (weeks); ses = 
Hollingshead socioeconomic status. 
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Table 5.7. Regression of AD in WM-ROIs with methamphetamine exposure (N=23). 
 
Methamphetamine 
(n=11) 
Control 
(n=12) 
     
WM-ROI (target1 – target2) Mean SD Mean SD βacq pacq βconf pconf Confounders included 
Midbrain - Right Caudate 1.469 0.069 1.455 0.061 -0.057 0.813 -0.057 0.813 none 
           
Midbrain - Right Putamen 1.467 0.050 1.440 0.034 0.153 0.507 0.153 0.507 none 
           
Midbrain - Left Caudate 1.486 0.075 1.440 0.060 0.129 0.589 0.021 0.932 age 
           
Midbrain - Left Putamen 1.466 0.044 1.472 0.076 -0.193 0.411 -0.227 0.384 marijuana 
           
Left NAcc - Left OFC 1.618 0.122 1.555 0.120 0.164 0.489 0.198 0.424 marital status 
           
Left Putamen - Left OFC 1.605 0.054 1.588 0.070 0.146 0.539 -0.030 0.893 age 
           
Right NAcc - Right OFC 1.622 0.107 1.583 0.099 0.146 0.540 0.146 0.540 none 
           
Right Caudate - Right OFC 1.703 0.067 1.683 0.096 0.167 0.467 0.107 0.651 age, birthweight, ses 
           
Right Putamen - Right OFC 1.632 0.078 1.593 0.081 0.271 0.248 0.113 0.612 age 
           
Midbrain - Right Hippocampus 1.682 0.084 1.705 0.079 -0.331 0.148 -0.331 0.148 none 
           
Right Putamen - Right Amygdala 1.507 0.046 1.518 0.054 -0.310 0.181 -0.310 0.181 none 
           
Right Putamen - Right Hippocampus 1.607 0.049 1.640 0.072 -0.264 0.250 -0.337 0.169 age 
           
Left Caudate - Right Caudate 1.875 0.115 1.816 0.108 0.383 0.097 0.277 0.226 age, sex 
           
Left Caudate - Left Hippocampus 1.678 0.122 1.709 0.144 -0.221 0.348 -0.305 0.218 age, ses 
           
Left Hippocampus - Left OFC 1.762 0.113 1.801 0.151 -0.189 0.425 -0.189 0.425 none 
          
NAcc = nucleus accumbens; OFC = orbitofrontal cortex; Xacq = value controlling for acquisition sequence in the analysis; Xconf = value following addition of acquisition 
sequence and significant confounding variables into analysis. Age = gestational age at scan (weeks); ses = Hollingshead socioeconomic status. 
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Table 5.8. Regression of RD in WM-ROIs with methamphetamine exposure (N=23). 
 
Methamphetamine 
(n=11) 
Control 
(n=12) 
     
WM-ROI (target1 – target2) Mean SD Mean SD βacq pacq βconf pconf Confounders included 
Midbrain - Right Caudate 1.028 0.039 0.986 0.068 0.422 0.059 0.422 0.059 none 
           
Midbrain - Right Putamen 1.002 0.035 0.970 0.046 0.381 0.099 0.381 0.099 none 
           
Midbrain - Left Caudate 1.029 0.043 0.988 0.056 0.319 0.166 0.144 0.494 age 
           
Midbrain - Left Putamen 1.002 0.045 0.982 0.067 0.136 0.569 0.032 0.900 marijuana 
           
Left NAcc - Left OFC 1.275 0.100 1.217 0.098 0.321 0.167 0.324 0.188 marital status 
           
Left Putamen - Left OFC 1.229 0.050 1.196 0.061 0.382 0.096 0.166 0.367 age 
           
Right NAcc - Right OFC 1.273 0.090 1.232 0.104 0.369 0.106 0.369 0.106 none 
           
Right Caudate - Right OFC 1.278 0.073 1.243 0.108 0.323 0.143 0.264 0.160 age, birthweight, ses 
           
Right Putamen - Right OFC 1.258 0.071 1.199 0.077 0.420 0.066 0.248 0.228 age 
           
Midbrain - Right Hippocampus 1.190 0.077 1.195 0.066 0.113 0.633 0.113 0.633 none 
           
Right Putamen - Right Amygdala 1.074 0.068 1.023 0.057 0.214 0.362 0.214 0.362 none 
           
Right Putamen - Right Hippocampus 1.084 0.032 1.078 0.078 0.108 0.642 0.002 0.995 age 
           
Left Caudate - Right Caudate 1.201 0.092 1.150 0.082 0.531 0.016 0.312 0.092 age, sex 
           
Left Caudate - Left Hippocampus 1.159 0.091 1.156 0.114 -0.006 0.979 -0.084 0.719 age, ses 
           
Left Hippocampus - Left OFC 1.238 0.070 1.252 0.120 0.023 0.921 0.023 0.921 none 
          
NAcc = nucleus accumbens; OFC = orbitofrontal cortex; Xacq = value controlling for acquisition sequence in the analysis; Xconf = value following addition of acquisition 
sequence and significant confounding variables into analysis. Significant results (p<0.05) are highlighted in boldface. Age = gestational age at scan (weeks); ses = 
Hollingshead socioeconomic status. 
Tables 5.7 and 5.8 show the results of the regression of AD and RD with methamphetamine 
exposure in the WM-ROIs that showed a significant or trend-level association between FA and 
methamphetamine exposure. No significant associations between AD and methamphetamine 
exposure were observed in any connection at any stage of the analysis. 
Increasing methamphetamine exposure was significantly associated with increased RD in the 
left caudate – right caudate connection, which became a trend after control for confounders. 
Trend-level associations were additionally observed in a further 2 connections (midbrain – 
right caudate; midbrain – right putamen). 
 
5.4 DISCUSSION 
This investigation forms part of the first study to use DTI tractography to examine the effects 
of prenatal methamphetamine exposure on white matter in neonates. As hypothesised, 
methamphetamine exposure was shown to be associated with reduced FA in several white 
matter connections, chiefly involving striatal structures, the midbrain and the OFC. The right 
hemisphere appeared more strongly affected, with 7 right and 4 left hemisphere connections 
observed to show alterations in FA at either a significant or trend level. Effects of 
methamphetamine on other diffusion measures were less global. No effects on AD were 
observed at all. RD, however, was observed to be increased in association with 
methamphetamine exposure in a subset of connections showing reduced FA. 
These results are in partial agreement with previous studies examining white matter alterations 
in children with prenatal methamphetamine exposure. In a study of 6-7 year-old children, 
methamphetamine exposed children had significantly reduced FA in left external capsule and 
fornix, measured in the putamen, pallidum, hippocampus, amygdala and OFC regions82. 
Similarly, infants with combined methamphetamine/ tobacco exposure were observed to have 
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reduced FA in superior, anterior and posterior corona radiata90. Both of these studies observed 
increased RD in the corresponding regions, in agreement with the findings of the current study. 
In the older cohort increased AD was also observed, although this was not found in the same 
regions which exhibited reduced FA82. Other studies of prenatal methamphetamine exposure, 
however, do not agree with these observations. Cloak and colleagues observed a trend towards 
increased FA in left frontal white matter in 3-4 year-olds with prenatal methamphetamine 
exposure, with significantly reduced diffusivity in frontal and parietal white matter. No 
alterations were observed in grey matter subcortical regions91. Similarly, increased FA was 
observed in older children (9-11 years) with prenatal exposure to methamphetamine and 
alcohol in a number of white matter tracts in the left hemisphere92. The latter study noted an 
overall reduction in diffusivity, including RD, in exposed children. In DTI studies of adult 
methamphetamine users, the findings are generally similar to those of the current study, with 
reduced FA noted in frontal white matter28,31,187 and CC29,30,187.  
The precise structural and functional significance of alterations in diffusion indices is a matter 
of some complexity. Anisotropic water diffusion in neural tissue is primarily a product of intact 
axonal membranes, with the presence and integrity of the myelin sheath playing a modulating 
role121. FA is thus generally regarded as a measure of the structural coherence of the white 
matter under consideration135, with higher FA reflecting greater restriction of diffusion and 
presumably more highly organised structure125. FA reductions have been shown to be 
associated with a number of neurodegenerative194,197,234 and psychiatric196,235,236  disorders. The 
nature of the white matter characteristics underlying changes in FA may, however, be 
multifactorial, and cannot be fully discerned from this measure alone. FA changes may be a 
consequence of altered myelin extent or structure237, damage to the axon fibres123 or changes 
in water content, such as in edema192. Reduced FA may be the result of increased RD or reduced 
AD, or a combination of alterations in both measures122,237, and investigation of these indices 
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can provide some elucidation as to the nature of the underlying pathology, as AD is generally 
more sensitive to axonal damage238, while RD changes have been shown to reflect changes in 
myelination239. 
As observed previously, in utero methamphetamine exposure was associated in the current 
study with reduced FA in a number of white matter connections. Investigation of the diffusion 
indices showed no changes in AD in any of the studied connections, while a subset exhibited 
increased RD in association with methamphetamine exposure. These findings indicate that the 
exposure to methamphetamine reduced the integrity of the white matter in the studied neonates, 
and suggests that this may be a result primarily of damage to or alterations in myelin. This 
pathology following methamphetamine exposure is supported by a variety of findings. In vitro 
methamphetamine treatment induces apoptosis in oligodendroglial cells in a dose- and time-
dependent manner203, and in animal studies prenatal exposure to methamphetamine has been 
shown to be associated with reduced myelination and myelin content of white matter201,202. 
Given that RD changes were observed in only a few connections, however, these conclusions 
should be drawn with caution. Methamphetamine has been associated with axonal degeneration 
in caudate, putamen204 and hippocampus240 and increased apoptosis of neurons in the olfactory 
bulb241. In DTI studies of methamphetamine abuse in adults, AD was shown to be decreased 
in the CC30 and increased in caudate-putamen31, while both studies showed an increase in RD. 
Studies of prenatal exposure have shown increased AD82,92, and both increased82,90 and 
decreased92 RD. Despite the lack of unanimity as to the exact direction of the alterations in 
diffusion indices, however, it can be assumed that the damage to white matter is the result of 
several factors. 
An additional consideration when interpreting diffusion data from infants, and one that adds 
considerable complexity, is that neural development is active and ongoing in neonates. Axonal 
organisation into fibre systems begins in the first trimester of pregnancy101, and at birth most 
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of the major white matter tracts are in place242. The process of myelination, however, is far 
from complete at birth129. White matter maturation is, additionally, region specific: it appears 
to follow a caudal-to-rostral and central-to-peripheral progression124, such that proximal 
pathways and central regions will be myelinated earlier and more rapidly than distal and polar 
ones101. Myelination also tends to occur earlier in functional systems that are used earlier in 
life than those that will be used later243, so that sensory pathways and projection fibres will 
mature sooner than motor and association connections129. Anisotropy has been shown to be 
present in white matter prior to myelination121, and is measurable even during gestation244, but 
the rapid and anatomically non-uniform development of the white matter postnatally results in 
a natural shift in diffusion measures121. A variety of factors may play a role in this, including 
increased fibre diameter and cohesion of tracts, myelination, reduced brain water and denser 
axonal packing208. As the white matter tracts mature, FA tends to increase while AD and RD 
decrease124,245. Given that in the current study methamphetamine exposure was associated with 
reduced FA and, in some cases, increased RD, there is the additional possibility that these 
changes may be an indication of slower maturation of neonatal white matter. Delayed 
maturation of serotonergic neurons in the frontal cortex246, and inhibited somatic and locomotor 
development209,210,247 have been observed in rats following treatment with methamphetamine 
in utero. There is also precedence for this interpretation in a study of infants with prenatal 
methamphetamine and tobacco exposure, which noted reduced FA and increased diffusivity in 
the corona radiata at 1 month, and demonstrated that the developmental trajectories of these 
indices were altered in comparison to healthy comparison infants90. However, given that 
studies have observed diffusion and anisotropy differences in white matter of older children 
with prenatal exposure, it is unlikely that the changes observed are purely an indication of a 
delay in white matter development. 
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The basal ganglia are involved in regulating much of the activity of the frontal cortex, including 
motor function and a range of cognitive and emotional behaviours96. The OFC and its 
connections with the striatum and associated subcortical limbic regions are involved in 
motivation and reward250, and alterations in these regions have been suggested to underlie some 
of the behavioural dysfunction observed in addiction251. Furthermore, children with prenatal 
exposure to methamphetamine exhibit structural and functional changes in striatal and limbic 
regions87,89,94,96. It is therefore unsurprising that methamphetamine exposure is associated with 
microstructural alterations in the white matter of the orbitofrontal-striatal circuit, as 
demonstrated in the current study. 
There are certain limitations inherent in studies of prenatal drug exposure which may be 
addressed by investigating effects during the neonatal period. One such weakness is the 
influence of postnatal environment. Children who are exposed to methamphetamine in utero 
are almost invariably born into a suboptimal environment81,84, which has itself been shown to 
exert a damaging influence on behavioural77,170 and neurostructural252–254 development. The 
potentially strong confounding effects of the postnatal environment can, however, be controlled 
to a substantial degree by investigating exposure effects in neonates, as in the current study. 
An additional advantage in an investigation of neonates is in the determination of exposure 
parameters. The women whose infants were studied here were recruited during pregnancy, and 
methamphetamine and poly-substance use was determined using a time-line follow-back 
method130,131. This provides a significant advantage over studies of older children, in which 
accurate determination of maternal drug use is difficult, and permits a more accurate measure 
of frequency of methamphetamine use and a more informed quantitative analysis of its effects. 
Only one previous study investigated the potential associations between increasing prenatal 
methamphetamine exposure and white matter diffusion properties91.  
134 
 
There are a number of limitations in the current study. The potential confounding effects of 
polysubstance exposure is almost inevitable in any study investigating prenatal drug effects93. 
This is a significant concern, as exposure to alcohol, marijuana and tobacco has been shown in 
a range of both clinical and preclinical studies to be associated with altered structure and 
function of the CNS135,220,222,255–258. Individuals in both control and methamphetamine-using 
groups in the current study drank alcohol and used cigarettes and marijuana. More 
methamphetamine-using mothers used each substance during pregnancy, although only 
cigarette use was close to significantly different between groups. Prenatal exposure to tobacco 
has been shown to increase FA in the frontal white matter223, and women using 
methamphetamine have been observed to smoke more cigarettes than women who smoke but 
do not use methamphetamine90, so that the effect of cigarette smoking on infant white matter 
is likely to be compounded in the methamphetamine group. However, the accuracy of 
substance use recall permitted by recruitment and interview during pregnancy enabled a 
quantitatively reliable measurement of these variables, and they were analysed as potential 
confounders and included where statistically relevant. The sample size was fairly small, 
although comparable to previous work82, and for this reason one must interpret the findings 
with a measure of caution. Alterations were, however, observed where they were expected, and 
in the hypothesized directions. In several WM-ROIs a trend was observed towards 
methamphetamine-associated changes, and with a larger cohort some might have reached 
significance. This should be inferred with caution, however259. As mentioned above, 
development of the CNS is far from complete at birth. This raises the possibility that effects 
observed during the neonatal period may be transient and resolve with maturation. Longitudinal 
investigations which follow cohorts from infancy as they mature will be invaluable in this 
regard. Given that our findings agree with previous results in both infants and older children, 
however, it is likely that the observed alterations will not resolve with age. 
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This is the first study, to our knowledge, to use DTI tractography to investigate 
methamphetamine-associated microstructural alterations in corticostriatal and limbic 
connections in neonates. The previous literature is equivocal, but the current results agree with 
findings of reduced anisotropy and increased RD in white matter connections in association 
with prenatal methamphetamine exposure, and extend them to show that these changes are 
measurable in infants in the first post-natal month. These alterations may well underlie a subset 
of the cognitive dysfunction exhibited by children with prenatal methamphetamine exposure. 
Further investigations will be essential to determine the extent to which methamphetamine-
induced white matter damage is associated with cognitive deficits. 
  
136 
 
 
 
 
 
 
 
CHAPTER 6 
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DISCUSSION 
Methamphetamine has long been known to be neurotoxic, with both animal studies and 
research in human users demonstrating a range of deleterious effects on the CNS. Exposure 
during the gestational period has been shown to be associated with increased risk of perinatal 
complications, and a range of cognitive, behavioural and affective changes have been observed 
in children with prenatal methamphetamine exposure. The current studies therefore aimed to 
investigate whether prenatal exposure to methamphetamine was associated with 
neurostructural changes in neonates. The women whose children were studied were drawn from 
the Cape Coloured community of Cape Town, South Africa, a region with high levels of abuse 
of methamphetamine.  
The first study examined potential volumetric alterations of subcortical and cerebellar regions 
by means of manual segmentation of anatomical MR images. Reduction in volumes of the right 
and left caudate nuclei, in addition to reduced total brain volume, were observed to be 
associated with increased methamphetamine exposure, and this finding remained significant in 
the right caudate nucleus following adjustment for confounding variables.  
The second part of the study used DTI to investigate possible white matter changes following 
prenatal methamphetamine exposure. Two analyses were used to assess changes in different 
aspects of white matter connections. Firstly, a whole-brain approach investigated possible 
changes in the three major classes of white matter connections, the commissural fibres and the 
projection and association fibres bilaterally. Methamphetamine exposure was shown to be 
associated with reduced FA in all five networks of white matter, and in individual WM-ROIs 
within the projection and association networks bilaterally. A subset of these regions also 
showed alterations in AD and – more frequently – in RD that were associated with 
methamphetamine exposure. The second DTI analysis examined the white matter that 
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connected regions which were traced in the anatomical study. Using a tractographic approach, 
the WM connections were assessed between the caudate, putamen and nucleus accumbens and 
the midbrain and OFC, and between these regions and the hippocampus and amygdala. In 
agreement with the findings of the first DTI analysis, reduced FA was observed to be associated 
with methamphetamine exposure in connections between the midbrain and striatal nuclei, and 
connections between these nuclei and the OFC. A small number of connections to the 
hippocampus and amygdala also exhibited FA changes in association with methamphetamine 
exposure. Increased RD was observed to be associated with methamphetamine exposure in a 
subset of these connections. 
These findings are in agreement with previous investigations of children with prenatal 
methamphetamine exposure. Reduced volume of the caudate nucleus following 
methamphetamine exposure in utero has been observed in several studies of older children93–
95,149. The literature is more equivocal as regards the effects of methamphetamine exposure on 
white matter, with some studies observing increased FA and reduced diffusivity in major white 
matter bundles91,92, in contrast to the findings of the current study, while others have found 
reductions in FA and increased diffusivity in white matter regions82,90, in agreement with our 
observations. Methodological differences may underlie these disparate findings, particularly as 
regards the tools of analysis of the structural and DT images. Despite these discrepancies, 
however, there is little doubt that prenatal methamphetamine is associated with neurostructural 
changes, at both volumetric and microstructural levels. As our findings have demonstrated, 
these effects are observable even in neonates. 
The precise mechanisms whereby methamphetamine induces damage in monoaminergic 
neurons are not fully delineated, but are likely multifactorial. There is considerable evidence 
that oxidative stress plays a pivotal role in the neurotoxicity of methamphetamine. Levels of 
reactive oxygen and nitrogen species in dopaminergic neurons are increased following 
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exposure to methamphetamine260,261, and lipid peroxidation products have been shown to be at 
higher levels in the caudate and prefrontal cortex of methamphetamine users262–264. These 
changes are likely the result of several processes225. The fundamental effect of 
methamphetamine is to increase dopamine levels, both at the extraneuronal level and within 
the cytosol of the presynaptic terminal13,179. Paradoxically, dopamine is thought to play a vital 
role in the neurotoxicity of methamphetamine. If not sequestered in presynaptic vesicles, 
dopamine is rapidly oxidised to form quinones, cysteinyls and other reactive species265,266 
which cause damage to proteins and lipids within the neuron267. Additionally, the products of 
dopamine oxidation appear to be at least partially responsible for inducing activation of 
microglia268. Microglial activation has been observed to be a significant response to 
methamphetamine exposure in both animal269–271 and human272 studies, and has been shown to 
play a role in its neurotoxicity159,271. It has been suggested that methamphetamine may 
exacerbate oxidative stress by promoting downregulation of cellular antioxidant 
mechanisms273 and inducing mitochondrial dysfunction274–276. Oxidative stress may 
additionally be involved in promoting the activity of the transcription factor p53, which is 
responsible for inducing apoptosis277.  
The mechanisms of methamphetamine neurotoxicity are likely not completely limited to its 
effects on monoaminergic neurons, however. Methamphetamine has been shown to cause 
reduced blood flow across the placenta57 and restricted supply of nutrients and oxygen to the 
developing fetus70. Analysis of placental development in the current cohort demonstrated that 
methamphetamine use during pregnancy was associated with greater placental size and 
increased intrauterine passing of meconium58. Both findings may be responses to chronic 
hypoxia, suggesting that the methamphetamine-exposed fetus may experience prolonged 
intervals of hypoxia-ischemia. White matter has been shown to be particularly vulnerable to 
hypoxic-ischemic insult278–280, with late oligodendrocyte progenitor cells most highly 
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susceptible to ischemia-induced apoptosis281–283. This may be a consideration in the current 
findings of somewhat widespread white matter changes following methamphetamine exposure.  
The basal ganglia are increasingly understood to be involved in the regulation of a diverse 
range of frontal cortical activities including motor function, cognition, executive function and 
decision-making, and reward-related and motivational processes248,249. Projections from frontal 
cortex to the basal ganglia are chiefly to the dorsal striatum, consisting of the caudate and 
putamen, and the ventral or limbic striatum, which includes the nucleus accumbens284. It has 
been postulated that corticostriatal connections exist in five parallel circuits, each projecting 
from a specific region of cortex to a defined area of striatum, which in turn projects back to 
that region of cortex via the thalamus285. Each circuit is then responsible for a specific set of 
motor, cognitive or affective functions based on its associated cortical region284. The motor and 
oculomotor circuits thus project from the supplementary motor area and the frontal eye fields 
respectively, while the dorsolateral, orbitofrontal and anterior cingulate circuits project from 
their eponymous cortical areas285 and are involved in the planning, modulation and expression 
of goal-directed behaviours106. This understanding of closed, parallel corticostriatal circuits has 
been challenged, however, by a growing body of research suggesting that specific areas of the 
striatum receive afferents from several cortical regions, including the OFC, dorsolateral 
prefrontal cortex and parietal cortex286–289. The convergence of corticostriatal afferents within 
the striatum is postulated to underlie the integration of reward and executive control in 
reinforcement learning290.  
The OFC plays a fundamental role in stimulus-reinforcement and reversal learning and thus in 
modulating motivational, emotional and social behaviour250, and is essential in the processes 
underlying inhibitory control and goal-directed behaviour291. It projects primarily to the ventral 
striatum, consisting of nucleus accumbens, ventral putamen and ventromedial caudate 
nucleus292, as well as to the head and body of the caudate292 and convergence zones within the 
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caudate and putamen in the dorsal striatum286. The ventral striatum receives input from the 
hippocampus and areas associated with the limbic regions such as the amygdala and ventral 
tegmental area in the midbrain293. As the primary circuit responsible for reinforcement, the 
striato-thalamo-orbitofrontal circuit and associated limbic-striatal areas has been postulated to 
be dysfunctional in drug addiction and to underlie the compulsive drug-seeking behaviour 
noted in addicted subjects251,294. 
A considerable body of evidence demonstrates alterations in components of this system 
following exposure to methamphetamine. In laboratory studies, methamphetamine 
administration has been shown to deplete dopamine levels295–297 and dopamine transporter 
binding298,299 and function296 in the striatum, as well as to induce dopamine terminal 
degeneration300 and apoptotic and necrotic cell death301 in this region. In the basolateral 
amygdala, methamphetamine treatment resulted in increased dopamine fibre density302. 
Increased expression of c-fos303 and GABA receptor subunit304 mRNA have been observed in 
the OFC of rats pretreated with methamphetamine, and deficits in discrimination reversal 
learning, analogous to impairments observed following OFC damage in humans, were 
demonstrated to occur following methamphetamine treatment299. Similarly, damage to these 
regions has been observed in studies of adult methamphetamine users. Reduced volume of the 
OFC22,183 and reduced activation of the OFC in decision-making tasks51,52 have been shown to 
be associated with methamphetamine abuse. Altered glucose metabolism in OFC, amygdala 
and ventral striatum was associated with increased affective symptomatology in 
methamphetamine users46, while in another study the severity of psychiatric symptoms was 
shown to correlate with reduced dopamine transporter density in the orbitofrontal and 
dorsolateral prefrontal cortices48. Reduced D2 receptor availability in the caudate-putamen in 
methamphetamine abusers was associated with increased metabolic activity in the OFC305.  
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Prenatal exposure to methamphetamine has been shown to produce similar results as exposure 
in adulthood. Animal studies of pre- or neo-natal methamphetamine treatment have 
demonstrated altered tyrosine hydroxylase and dopamine transporter mRNA levels in 
substantia nigra and ventral tegmental area306–308, as well as altered dopamine and dopamine 
metabolite levels in the nucleus accumbens163 and glutamate receptor expression in the 
hippocampus309. Mice exposed to methamphetamine in utero showed significantly increased 
impulsivity, reduced inhibitory control and heightened motivation for reward310, behavioural 
characteristics which mimic core symptoms of addiction in humans and may indicate 
dysfunction in the striato-frontal cortex circuits. Similarly, children with prenatal 
methamphetamine exposure have been shown to have reduced caudate, putamen and 
hippocampal volumes94,96 and altered metabolism in the striatum89, and to exhibit lower 
activation in OFC and putamen in the performance of a working memory task87.  
The current findings of reduced volume of the caudate and decreased FA in the cortico-striatal 
circuits and associated limbic connections are thus unsurprising, and provide support for the 
consideration that the damage induced by methamphetamine exposure is not limited to cortex 
and subcortical structures but includes the white matter bundles connecting them. Furthermore, 
damage to these circuits has significant cognitive implications. Caudate volume has been 
shown to be a strong predictor of neurocognitive performance in children with fetal alcohol 
spectrum disorders311 and autism312. In children with prenatal exposure to methamphetamine 
and alcohol, volume of the caudate was shown to be related to measures of intelligence93. 
Microstructural damage to the orbitofrontal-striatal circuit has repeatedly been demonstrated 
in individuals with a clinical diagnosis of ADHD313–315. Reduced generalised FA in the 
orbitofrontal-striatal connection has been associated with increased inattention313,314, impaired 
executive function and severity of clinical symptoms316 in children with ADHD. Children with 
prenatal methamphetamine exposure have a significantly increased incidence of ADHD79,81 
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and increased measures of ADHD clinical symptoms85. Prenatal methamphetamine exposure 
has been associated with significantly poorer performance on tasks of sustained attention94,95 
and inhibitory control84 and increased risk of neurobehavioural disinhibition83. It is not 
unreasonable to speculate that alterations in the corticostriatal circuits such as those 
demonstrated in the current studies may, at least in part, underlie some of the cognitive deficits 
exhibited by methamphetamine-exposed children.  
In the light of the current findings, there are multiple avenues for future investigation. The 
uncertainty as to the long-term nature of the findings warrants a scrutiny of the developmental 
trajectories of exposed children. It is additionally of importance to investigate whether the 
current structural findings are associated with or predictive of functional alterations in the 
specific modalities discussed above. These findings and future investigations arising from them 
are of vital significance for the development of appropriate and adequately informed 
interventions. 
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